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ABSTRACT
INVESTIGATION OF BOVINE CONCEPTUS GALECTINS AND THE EFFECT OF
BOVINE CONCEPTUS SECRETORY PROTEINS ON THE ENDOMETRIAL EPITHELIAL
TRANSCRIPTOME

Heather L. Baldwin
Pregnancy loss in cattle is greatest in the first 30 days of gestation. Near d15 of gestation,
bovine conceptuses elongate and express LGALS1, an immunosuppressive glycan-binding protein
believed to be essential for implantation. However, other members of the bovine galectin family,
including LGALS3, LGALS4, LGALS7, LGALS8, LGALS9 and a galectin-13-like gene
(LGALS13L), also may be expressed by the elongating conceptus. Therefore, galectin expression
in elongating, d16 bovine conceptuses and intercaruncular endometrium as well as elongating, d14
ovine conceptuses and intercaruncular endometrium was assessed by RT-qPCR. Angus heifer and
Texel ewes underwent estrous cycle synchronization and either inseminated or not bred. On d16
(heifers) or d14 (ewes) after synchronized estrus (d0), reproductive tracts of pregnant (heifers,
n=4; ewes, n=3) and cyclic (heifers, n=4; ewes, n=3) animals were removed. Conceptuses and
intercaruncular endometrial samples were then collected. Conceptuses and intercaruncular
endometrium samples were individually snap frozen and stored at -80°C until RT-qPCR. Bovine
and ovine conceptus gene expression was normalized to control genes GAPDH and YWHAZ, and
endometrial gene expression was normalized to control genes H3F3A and RNF11. A general linear
model procedure (PROC GLM) in SAS was used to test for differences. For the conceptus data,
alpha was set at 0.05, and a Tukey’s test was included in the analysis. Conceptus data are presented
as non-transformed means ± standard deviation (SD) of the mean. Endometrial data are presented
as non-transformed least square means (LSM) ± standard error of the mean (SEM) and P ≤ 0.05
was considered significant. In bovine conceptuses, expression of LGALS3 (24.47 ± 6.41) and
LGALS1 (21.80 ± 2.07) was similar, yet, greater than all other galectins measured (α = 0.05).
Expression of LGALS8 (1.73 ± 0.27) was 12-fold less than LGALS1, however, LGALS8
expression was greater than LGALS9 (0.77 ± 0.77), LGALS13L (0.30 ± 0.10), LGALS4 (0.08 ±
0.01) and LGALS7 (0.02 ± 0.01) (α = 0.05). In bovine intercaruncular endometrium, expression
of LGALS1, LGALS8, and LGALS9 were greatest. Compared to cyclic heifers, endometrial
expression of LGALS7 was less (5.80 ± 2.35 and 2.62 ± 2.35; cyclic and pregnant, respectively;
P ≤ 0.05), while expression of LGALS9 (9.26 ± 2.25 and 24.56 ± 2.25; cyclic and pregnant,
respectively; P ≤ 0.001) and LGALS3 were greater (2.62 ± 0.52 and 4.40 ± 0.52; cyclic and
pregnant, respectively; P ≤ 0.05) during pregnancy. In sheep conceptuses, expression of LGALS3
(4.30 ± 0.78), LGALS1 (1.90 ± 0.25) and LGALS8 (1.68 ± 0.25) were similar. Compared to all
other galectins measured, LGALS4 (0.20 ± 0.10) had the lowest level of expression (α = 0.05). In
ovine intercaruncular endometrium, expression of LGALS3, LGALS8, and LGALS15 were
greatest. Compared to cyclic ewes, expression of LGALS7 was greater in pregnant ewes (0.81 ±
0.24 and 2.25 ± 0.24; cyclic and pregnant, respectively; P ≤ 0.05) while LGALS4 (3.10 ± 0.38 and
1.78 ± 0.38; cyclic and pregnant, respectively; P = 0.06) tended to be less during pregnancy and

LGALS15 tended to be greater during pregnancy (104.30 ± 234.20 and 591.35 ± 234.20, P = 0.07;
cyclic and pregnant, respectively). In conclusion, elongating bovine and ovine conceptuses express
various members of the galectin gene family, and select galectin genes are differentially expressed
in the endometrium during pregnancy. The galectins may have important functions during early
pregnancy in ruminants.
Interferon-tau (IFNT), secreted by the elongating bovine conceptus, is the maternal
recognition of pregnancy signal that suppresses the endometrial luteolytic mechanism by
modifying expression of genes in specific cell types within the endometrium. The conceptus also
secretes galectin proteins, specifically galectin-3. This study assessed the effect of IFNT
(Experiment 1) and LGALS3 (Experiment 2) on bovine endometrial epithelial and fibroblast cell
transcriptomes when the mid-luteal phase endometrial cells were cultured in a 3D environment. In
Experiment one, epithelial cells, cultured in Transwell inserts above the fibroblast cells, were
treated with RPMI media alone (control; n=4) or treatment media (RPMI with 5% FBS and 1%
ABAM) containing 100 ng of recombinant ovine IFNT (n=3) for 6 h. In Experiment two, cells
were treated with either RPMI media alone (Control; n=5), pregnant ovine uterine flush fluid,
theoretically containing INFT, diluted with treatment media 1:1 (n=4), or treatment media (RPMI
with 5% FBS and 1% ABAM) containing either 100 or 1000 ng of recombinant mouse LGALS3
(n=5) for 6 h. Total RNA was extracted from both cell types and the transcriptomes were assayed
by RNA Sequencing and RT-qPCR. Interferon-tau regulated 673 and 83 genes (differentially
expressed genes or DEGs) in epithelial and fibroblast cells, respectively (P ≤ 0.001; FDR P ≤ 0.05).
Many of the DEGs identified in the epithelial (205) and fibroblast cells (64) were previously
reported as IFNT and bovine conceptus-induced DEGs in intact bovine endometrium, including
well-known ISGs such as ISG15, MX1, MX2, OAS1, and OAS2. Surprisingly, the ZC3HAV1
gene, which was recently found to be up-regulated in intact bovine endometrium in response to
the conceptus, was only up-regulated in fibroblast cells despite applying IFNT to the apical surface
of the epithelial cells in 3D culture. The RNA-Seq analysis of the bovine endometrial cells treated
with mouse LGALS3 protein resulted in the identification of a single gene, RPL23A, that was
upregulated in epithelial cells treated with 100 ng of LGALS3 (P ≤ 0.001; FDR P ≤ 0.05). This
study supports the idea that the 3D culture of bovine endometrial cells may be utilized to study
early conceptus-maternal crosstalk and identify endometrial cell type-specific responses to the
conceptus.
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CHAPTER ONE

LITERATURE REVIEW
Introduction
The beef cow/calf industry experiences an annual loss exceeding $1.2 billion, with the
largest contributing factor being embryonic loss [1]. The highest incidence of pregnancy loss in
cattle occurs during the embryonic period of gestation, with 40% occurring between day (d) 8
and 17 [2-4]. The critical period for maternal recognition of pregnancy in cattle is d15-16
meaning that, in this time period, the conceptus begins to elongate in structure and secretes a
substance to communicate with the dam the presence of a pregnancy and to convert the corpus
luteum (CL) of the estrous cycle to a CL of pregnancy [5]. This secretory protein of the bovine
trophectoderm is called interferon tau (IFNT) and its presence stimulates the expression of
interferon-stimulated genes (ISGs) in the endometrium. The endometrial ISGs are considered
classical or nonclassical and alter the endometrium in preparation for embryonic attachment and
a successful gestation. Integrin proteins are imperative to attachment as they serve as a ligand for
extracellular matrix compounds such as fibronectin. Galectins, specifically LGALS3, have been
shown to interact with integrins to promote antiapoptotic effects during the period of
implantation in humans and could promote adhesion between the conceptus and endometrium
[6]. The purpose of this chapter is to review the literature that has contributed to the current
understanding of the establishment of pregnancy in cattle, the origins of embryonic loss, and the
possible involvement of LGALS3 during early pregnancy in cattle.

1

The Bovine Estrous Cycle
The female cow will reach puberty at approximately one year and will begin her
reproductive cycle. The cycle is referred to as the estrous cycle with the time point of being
sexually receptive termed “estrus”. Approximately every 21d, a cyclic cow or heifer has the
chance to become pregnant as the cycle is continuous. The estrous cycle is defined as the period
from one standing estrus to the next and consists of four stages; proestrus, estrus, metestrus, and
diestrus [7]. Each estrous cycle can be divided into two phases, the follicular and luteal phases.
The follicular phase consists of 20% of the estrous cycle and includes both proestrus and estrus.
Proestrus continues from d17 to d20 of the bovine estrous cycle.
The beginning of the follicular phase, proestrus, is a result of luteolysis and is driven by
alternations in the endocrine profile. Luteolysis marks the beginning of the follicular phase and
is characterized by the regression of a functional CL due to uterine produced prostaglandin F2
alpha (PGF). Progesterone (P4) synthesized by the CL develops after the expulsion of an oocyte
from a follicle and prevents further ovulation. Regression of the CL and subsequent decline of
circulating P4 allows for gonadotropin-releasing hormone (GnRH) to be released from the
hypothalamus at a higher amplitude and frequency. Luteinizing hormone (LH) and follicle
stimulating hormone (FSH) are released from the anterior pituitary. The regulation of the two
differs as FSH is controlled by negative feedback from inhibin and estrogen, both originating
from developing follicles. The pulse frequency of LH is controlled by the pulses of GnRH. The
FSH aids in the development of follicles during proestrus by recruiting a cohort of follicles at the
start of every follicular wave. Sirois and Fortune (1988) developed a model of bovine follicular
development and regression by utilizing ultrasonography. Findings suggested that follicular
development in heifers occurs in wave-like patterns while during each wave, a selected follicle
2

increases in size and asserts dominance on other developing follicles [8]. The selection process
begins several days in advance to the dominant follicle reaching a preovulation diameter and
causes regression of other developing follicles. The LH aids in selection which is the further
development of the dominant follicle. Increased follicular development results in elevated
inhibin production from granulosa cells which inhibits further FSH secretion. Following either
atresia of the developing follicle or ovulation of the oocyte, FSH levels will once again rise to
initiate another follicular wave [7].
The production of estradiol (E2), in large concentrations, will result in positive feedback
on hypothalamic GnRH secretion leading to the preovulatory LH surge. This will trigger
“standing estrus” meaning the female will become sexual receptive while exhibiting behavioral
signs such as lordosis, increased movement, and the mounting of other animals. In cattle, estrus,
which is a result of the LH surge, lasts approximately 15-18 h and ends at ovulation on d0
marking the end of the follicular phase. Ovulation typically takes place 30 h after the initiation of
estrus [7].
The luteal phase, which begins after ovulation, consists of metestrus and diestrus and
continues from d0 to d17 of the estrous cycle. Triggered by the preovulatory LH surge, the CL is
formed from a newly ovulated follicle following luteinization in which the theca interna and
granulosa cells of the follicle differentiate into small and large luteal cells, respectively. A corpus
hemorrhagicum (CH) is the structure present immediately after ovulation as a result of the
rupture of blood vessels as the oocyte complex is released from the follicle. The CH will then
transition into a functional CL between d3 to d5 of the estrous cycle. Metestrus is characterized
by the development of a functional CL and the transition to elevated P4 levels and declining E2.
During this time, the first polar body appears as the oocyte undergoes meiosis. Corpus luteum
3

mass is directly correlated with CL P4 secretions levels as both plateau in the middle of the cycle
[9].
Thecal and granulosal cells intermix post-ovulation and both contain the capability to
produce P4. The P4 targets the hypothalamus to suppress GnRH and consequently, LH and FSH,
by decreasing GnRH receptors located on gonadotrophs in the anterior pituitary. The uterine
environment is influenced by P4 by aiding in endometrial secretions, termed histotroph, as well
as restricting contractility of the myometrium. In addition, P4 has the ability to aid in mammary
gland development. Granulosa cells form large luteal cells while thecal cells form small luteal
cells. Large luteal cells, as a result of ovulation, possess secretory granules that contain oxytocin
which will be critical for luteolysis [10].
The end of the luteal phase is marked by the occurrence of luteolysis which is induced by
endometrial PGF. Luteolysis is characterized by a 1-3d regression of the CL resulting in reduced
blood P4 levels. The PGF originates in the uterine epithelium and travels to the ovary to initiate
luteolysis through a vascular countercurrent exchange between the uterine vein and ovarian
artery [11]. This system enables PGF to be transported to the ovary avoiding dilution and
metabolism that would occur in general circulation [7]. A large portion of PGF secreted by the
uterine epithelium travels through the utero-ovarian vein and diffuses into the ovarian artery. The
PGF can initiate apoptosis in luteal cells. As a result, blood P4 concentrations decrease and the
cycle will transition into a new follicular phase characterized by elevated E2 levels.

Early Bovine Pregnancy
Once the physiological and hormonal profiles are precise, the oocyte will ovulate—
allowing the oocyte to migrate to the oviduct. In cattle, past research has shown that the number
4

of ovulations occurring in the right compared to the left ovary is not proportionate with the right
ovary having a greater ovulation rate [12, 13]. Following ovulation, the infundibulum captures
the ovulated oocyte and permits the oocyte to travel to the ampulla-isthmic junction (AIJ) for
possible fertilization. During natural mating, spermatozoa travel from the site of deposition, the
cranial vagina, through the reproductive tract, to the AIJ [7].
If fertilization is successful, the presence of both the male and female pronuclei within
the oocyte’s cytoplasm confirms the existence of an ootid. The male pronucleus is formed once
the sperm nucleus enters the oocyte’s cytoplasm. The male pronucleus then undergoes
decondensation allowing the female and male pronuclei fuse together to form a single nucleus.
The resulting zygote is composed of a single cell [7]. Within 24 h, the single-celled embryo will
undergo cytokinesis and will cleave into a two-celled embryo with two blastomeres. Blastomere
cleavages will continue, where the two-cell embryo will cleave into a four-cell embryo followed
sequential cleavages. It is also important to note that early embryonic development, until d5,
occurs within the oviduct which has unique secretions in comparison to the uterine horns. The
oviduct provides an optimal environment for the developing conceptus by providing a specific
combination of amino acids, energy substrates, and ions [14-16]. Past research has also found
that the presence of oviductal cells or oviduct conditioned media during culture improves
embryo viability [17].
Near d4, the embryo becomes a morula. Visually, the morula is identified as a solid mass
of cells which cannot be easily distinguished from one another and quantified. During this time,
the developing conceptus, which refers to the embryo body and extra-embryonic tissues, is
transferred from the oviduct into the uterus. Tight junctions between the outer cells of the morula
aid in the accumulation of fluid within the intercellular spaces inside the morula. Sodium is
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pumped into the intercellular space and, consequently, water accumulates. Blastocyst formation
occurs around d7 of pregnancy in cattle. The blastocyst contains a fluid-filled cavity termed a
blastocoele which consists of two distinct cell populations. One population forms the inner cell
mass, which will give rise to the body of the developing embryo. The other cell population forms
the outer layer and is referred to as trophoblast cells which will develop into the chorion of the
placenta [7]. Lastly, between d7-8 of pregnancy, the blastocyst will hatch from the zona
pellucida. At this point, the blastocyst is exposed to the uterine secretions. Expulsion of the
blastocyst is a result of increasing internal pressure due to a combination of early embryonic
growth, the enzymatic degradation of the zona pellucida, and contraction of the conceptus [7].
Once hatched from the zona pellucida, the embryo undergoes dramatic morphological
change, increasing in size from around 0.15 mm in diameter to over 60 mm in total length due to
the process of elongation [18]. The bovine embryo will double in length every day between d916 of gestation [19-21]. The sphere-shaped blastocyst will transform into an ovoid conceptus on
approximately d12. Finally, the conceptus will transition into a tubular structure on
approximately d13-14 of gestation [22]. The conceptus will span both uterine horns by d18 of
gestation, later attaching to the uterine surface [7]. Alterations of the uterine environment,
including histotroph gene expression, are mediated by an increased concentration of P4 which
promotes rapid conceptus growth [23]. Uterine histotroph consists of enzymes, growth factors,
cytokines, hormones, transport proteins, and other substances [20, 24-27]. During this time, the
extraembryonic membranes of the pre-attachment embryo rapidly develop and are comprised of
the yolk sac, chorion, amnion, and allantosis. Bovine pre-attachment blastocysts are
characterized by having a filamentous and thread-like structure near d16-17 [22].
As the development of the embryo progresses beyond the blastocyst stage, a dependency
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on the maternal uterine environment develops. Bovine blastocysts can be produced by in vitro
fertilization (IVF) technology; however, the uterine environment is essential for the elongation of
the developing conceptus [28, 29]. Ex vivo, outside of the uterus, ruminant blastocysts are unable
to elongate as histotroph from endometrial glands is essential for this process [30, 31]. Gray and
coauthors (2002) utilized uterine gland knockout (UGKO) sheep to investigate the role of
endometrial secretions on elongation. The UGKO ewes were generated by utilizing synthetic
progestin which results in the lack of uterine glands after postnatal chronic exposure in ewe
lambs [31]. In sheep, conceptuses normally elongate around d14 of gestation. Day 14
conceptuses from UGKO ewes were observed to be fragmented, growth-retarded, and tubular. In
addition, it was concluded that development was interrupted in embryos from knock-out gland
ewes due to lack of endometrial glands opposed to alterations in the expression of molecules that
impact adhesiveness of the luminal epithelium [30].
Maternal Recognition of Pregnancy
Reciprocal communication takes place between the embryo and the uterine environment.
Increased levels of steroid hormones, P4 and E2, affects uterine gland gene expression
promoting elongation and growth of the conceptus. Progesterone also controls the expression of
genes that aid in uterine receptivity to the conceptus. Uterine receptivity is essential for
embryonic growth, development, and attachment [20, 32]. In addition, the conceptus will release
proteins, steroids, and other factors that affect endometrial cell gene expression. Conceptus
IFNT, a cytokine, causes modifications to endometrial PGF production that disrupts luteolysis
allowing continuous P4 synthesis [33]. This process is termed maternal recognition of pregnancy
and must occur between d15-16 of gestation for pregnancy to successfully continue. Trophoblast
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cells are characterized into two groups: trophoblast mononucleate cells (TMC) and trophoblast
binucleate cells (BNC) [34]. The TMCs are responsible for the secretion of the maternal
recognition of pregnancy factor in ruminants. IFNT will then inhibit the transcription of the
oxytocin receptor (OTR) in the LE/sGE of the uterus by first silencing estrogen receptor alpha
(ESR1) expression [33, 35]. In the absence of oxytocin, luteolytic pulses of PGF cannot occur,
thus prolonging the CL lifespan. Comparing pregnant to cyclic animals, basal levels of PGF and
prostaglandin E2 (PGE2) in pregnant animals remain elevated due to continued uterine
prostaglandin synthase 2 (PTGS2) expression [35]. The silencing of ESR1 by IFNT disables E2
from inducing endometrial epithelial progesterone receptor (PGR) transcription which allows
stromal cells expressing PGR to regulate expression of ISGs [36].
Ulbrich et al. (2009) quantified prostaglandins (PGs) in the uteri of preimplantation
pregnancy stage heifers in comparison to non-pregnant control heifers. It was found the presence
of an embryo influenced the intrauterine environment of d15 pregnant heifers to consist of higher
concentrations of prostaglandin I2 (PGI2) and secondly, PGF, both of which were greater than
PGE2 [37]. Overall, clear evidence was found that the ratio of PGF/PGE2 was not altered
between cyclic and pregnant heifers as the embryo contributes to the PG environment. Likely,
PGI2 plays a role in the permeability of maternal vasculature. Both PGE2 and PGI2 have been
found to be critical during the regulation of implantation and decidualization in other species
including humans and mice [38, 39].
Interferon-tau is a type I interferon. Type I interferons are important in most viral
defenses. Type I interferons bind the interferon alpha receptor (IFNAR) to signal a response
biologically while the single Type II interferon family member, interferon gamma (IFNG) binds
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interferon gamma receptor (IFNGR) [40]. The pregnancy recognition signal, IFNT, will
differentially impact gene expression of cells in the luminal epithelium (LE), deep glandular
epithelium (dGE), surface glandular epithelium (sGE), and stroma [36, 41]. The ISGs and are
suggested to play various roles in the differentiation of the endometrium in preparation for
pregnancy. There are two distinct classifications of ISGs, classical and non-classical, which are
spatially stimulated by IFNT within the stroma/dGE and LE/sGE, respectively [42, 43]. Type I
and II IFNs initiate the expression of classical ISGs through stimulation of janus-associated
kinases and signal transducers and activators of transcription (Jak-STAT) pathways resulting in
phosphorylation of their respective receptors activating STAT.
There is a greater understanding of IFNT mediated ISG effects in the ovine endometrium
compared to cattle. The working hypothesis is as follows: conceptus-derived IFNT binds its
receptor, IFNAR, in the LE/sGE. There, interferon regulatory factor 2 (IRF2), which is a
transcriptional repressor, is up-regulated. The IRF2 inhibits ISGs which are considered
classically activated such as STAT1, STAT2, interferon regulatory factor 9 (IRF9), beta-2
microglobulin (B2M), ISG15 ubiquitin-like modifier (ISG15), major histocompatibility complex
(MHC), and oligoadenylate synthetase (OAS). However, IFNT is able to activate genes in the
non-classical category of ISGs such as cystatin-3 (CST3), cathepsin-L (CTSL), and galectin-15
(LGALS15) in the LE/sGE of sheep through a currently unknown biological cell-signaling
pathway [42]. Inversely, dGE and stromal cells lack expression of IRF2 resulting in activation of
JAK1 and tyrosine kinase-2 (Tyk2), and consequently, STAT2. Once STAT2 is phosphorylated,
STAT1 is able to become phosphorylated as well. With STAT1 and 2 activation, interferonstimulated gene factor-3 (ISGF3) and interferon regulatory factor-1 (IRF1) transcription factors
become activated allowing for the transactivation of classical ISGs [42, 44]. The LE and sGE
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may lack classical ISG expression during early pregnancy as a method of defense against the
immune rejection of the partially genetically dissimilar conceptus [45, 46].
The BNCs of the trophoblast appear between d18 and 20 of gestation in cattle and
migrate from the chorionic tissue to the maternal endometrium where they secrete factors such as
placental lactogen (PL) and pregnancy-associated glycoproteins (PAGs). The BNCs also secret
PG, along with estrogens, during preimplantation development. The BNC derived PAGs are
believed to play a role in the regulation of placentation, mammogenesis, steroidogenesis, and
immune function [47-50]. Other vital trophoblastic secreted molecules include Bcl-2-related
protein A1 (BCL2A1) which is BNC derived and is an imperative anti-apoptotic factor involved
in cell maintenance [51]. Bovine TMCs and BNCs, along with maternal tissues, have been found
to contain secreted protein of Ly-6 domain 1 (SOLD1) which plays various roles including
reconstruction of the post-partum uterus, fetal and placental growth, and placental expulsion.
Further, investigators found SOLD1 is involved in trophoblast cell migration and induced
invasion [52, 53].
Bovine Embryonic Attachment
Implantation of the developing ruminant conceptus is rather non-invasive and consists of
the process by which the fetal membranes attach to the maternal endometrial epithelium. Bovine
embryonic attachment occurs near d21 of gestation, a time when the allantois formation becomes
apparent macroscopically [54, 55]. Post-elongation, the conceptus will begin to attach to the LE
while trophoblastic projections become incorporated into the openings of the maternal uterine
glands [56]. The driving force of preparation of the endometrium for attachment of the
developing conceptus is P4 [35, 57]. Implantation is accompanied by increased production of
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secretions by the epithelial cells within the uterine lumen.
Past research in cattle and sheep has found certain histotroph components to be of
significant importance during the attachment phase [30, 42]. Successful implantation requires a
normally developed blastocyst, a receptive endometrium, and corresponding communication
between the two—a process which is orchestrated by various cytokines and growth factors such
as interleukin-10 (IL-10), leukemia inhibitory factor (LIF), colony-stimulating factors (CSF),
interleukin-1 (IL-1), and insulin-like growth factor 1 (IGF-1) [58, 59]. Members of the family of
proteins called integrins (ITGs) are imperative for successful implantation [60]. Integrins serve
as a receptor for fibronectin, vitronectin, laminin, collagen type IV, and osteopontin—all of
which compose the extracellular matrix [60-62]. Interferon gamma-inducible protein 10 (IP10),
LGALS15, and insulin-like growth factor-binding protein 1 (IGFBP1), all of which are
components of the uterine histotroph, have been described to induce ITGs during the attachment
of the trophectoderm to uterine tissue [61, 63-65].
Growth factors that are endometrial and/or conceptus derived, such as tumor necrosis
factor alpha (TNF), initiate direct communication between the maternal and trophoblastic cells.
The pro-inflammatory cytokine, TNF, is involved in various cellular activities including cell
differentiation, survival, and tissue homeostasis. The TNF has the capability to bind two
distinct receptors, TNF receptor 1(TNFR1) or TNF receptor 2 (TNFR2), which can have
dissimilar functions. Interestingly, TNFR1 activation is involved in cell apoptosis while TNFR2
can be involved in either cell proliferation or apoptosis. Along with TNFR2, TNF protein and
mRNA have been found to be expressed in pregnant and cyclic endometria of cattle and
expressed in endometrial and placental tissues of other species including humans during early
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and late gestation [66, 67]. It is speculated that nuclear factor kappa B (NFB), a transcription
factor that is activated by TNF, is down-regulated in the blastocyst to suppress immune
function during blastocyst formation. The endometrium is believed to regulate TNF
concentrations via controlling the secretion of TNF into the histotroph as well as regulating the
embryo’s transcription of both TNF and TNFR2 mRNA [67]. TNF has been shown to
stimulate PGF synthesis in endometrial stromal cells and IFNT has been shown to have an
inhibitory effect on TNF [68].
Preimplantation factor (PIF) is a peptide found to be secreted by murine, human, and
bovine embryos, as well as placental tissue. Additionally, PIF has been found to be in human
maternal general circulation [69, 70]. Trophoblastic PIF is expressed largely in the first and
second trimesters and may be an indication of viable embryos that are in vitro produced by
determining culture medium levels [71]. Human decidua cells cultured with PIF exhibited a role
in immune regulation, adhesion, and regulation of apoptotic processes [72].
Early Pregnancy Loss in Cattle
Embryonic mortality is defined as the loss of pregnancy from the time of conception to
d45 of gestation in cattle with early embryonic loss occurring from d0-27 and late embryonic
loss occurring from d28-45 of gestation [73]. Most pregnancy losses occur in the first 50 days of
gestation with losses before d20 attributing to 75% of all reproductive failures [74, 75]. Revenue
from both dairy and beef farms depend on reproductive success. Therefore, it is important to
address the causes of early embryonic loss to minimize financial loss. Reported fertilization rates
in beef cattle are high, with values ranging from 93-96% when insemination occurs at the proper
time in relation to ovulation [76-78]. Most reproductive failure following insemination occurs
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post-fertilization. Methods known to minimize loss during the first eight days of pregnancy
include alleviating heat stress, inflammatory diseases, body condition loss, and by increasing
preovulatory follicular development progesterone levels as this time period comprises 20-50% of
all embryonic loss [18]. Researchers addressed the role of a persistent follicle (PF) on early
embryonic loss and found evidence that an oocyte from a PF is capable of becoming fertilized
but exhibited a disability to grow into a 16-cell stage embryo [76]. The reduction in fertility is
due to biochemical and morphological alterations that take place within a follicle that remains
dominant for an extended period of time [75]. Along with an altered endocrine profile, studies
have shown the occurrence of PF in cattle is accompanied by altered follicular steroid and
gonadotropin receptor expression [79-81].
Galectin-3
Galectin-3 (LGALS3) is located on chromosome 10 in cattle and is a member of a large
family of -galactoside-binding animal lectins that have numerous physiological functions.
Lectins bind carbohydrates and result in cell agglutination while playing vital roles in pathogen
defense, cell trafficking, and immune regulation [82, 83]. Currently, 15 members have been
identified in mammals [84]. Galectins are ancient members of a lectin family which are
characterized by having conserved amino acid sequences with at least one carbohydrate
recognition domain (CRD) and the ability to recognize -galactoside structures located on cell
surface glycoconjugates [85, 86]. Galectin family members have been categorized into three
groups based on the number and organization of CRDs present: 1) the prototype, consisting of a
single CRD, 2) the chimera type, whose only member is LGALS3 and consists of one CRD
along with a non-lectin domain, and 3) the tandem repeat which consists of a short peptide linked
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by two CRDs [82, 87, 88].
Galectin-3 is a 29 to 35 kDa protein and consists of a 110-130 amino acid N-terminal
domain connected to glycine and proline-rich repeats, along with a single C-terminal CRD [87].
A conformational change occurs when LGALS3 or its CRD interact with carbohydrate ligands
leading to rearrangement of the backbone loops located nearby its binding site. Multiple ligands
of LGALS3 have been identified and include extracellular glycoproteins and glycolipids [89,
90]. N-terminal domain and CRD have been shown to interact in the formation of LGALS3
multimers as LGALS3 possess bivalent and multivalent binding properties [87, 91]. It is also
unique in that it is the only chimera-type galectin found in vertebrates and has been discovered in
various cell types including tumor cells, macrophages, activated T cells, epithelial cells, and
fibroblasts. The localization of LGALS3 protein is dependent on the cell type as LGALS3
protein has been reported to be found in the cytoplasm or secreted through non-classical
pathways [87, 92]. Galectin-3 does not contain an N-terminal signal sequence and becomes
externalized through an endoplasmic reticulum-Golgi complex independent mechanism [93].
Also, LGALS3 may translocate to the nucleus or become secreted via a non-classical pathway of
secretion following its cytoplasmic ribosomal synthesis. [94-96]. Intracellularly, LGALS3 has
been shown to interact with nuclear and cytoplasmic proteins leading to the modulation of
signaling pathways [86]. In addition, intracellular LGALS3 mediates anti-apoptotic effects by
inhibiting apoptosis caused by nitrogen-free radicals [97]. Extracellular LGALS3 binds to
oligosaccharides located on the surface of cells and promotes apoptosis by the release of
cytochrome c and caspase-3 activation [98].
Galectin-3 has functions in the regulation of the immune response and may be involved
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in the development of cancer and heart disease. Galectin-3 is also involved in various biological
processes including cell adhesion, cell activation, chemoattraction, proliferation, cellular
differentiation, and apoptosis [84, 87, 99]. Regarding immunology, LGALS3 is a regulator of
inflammation and is secreted by macrophages, monocytes, dendritic cells, eosinophils, mast
cells, natural killer cells, and both activated B and T cells [89, 100].
Cancer researchers have determined that LGALS3 promotes tumor cells growth in certain
cancer types while promoting anti-apoptotic effects on tumor cells in various other cancers [101].
Contrarily, in cancers such as breast, non-melanoma skin, prostate, endometrial, and leukemia
cancers, LGALS3 exerts tumor suppression effects on cancerous cells [102]. In the case of
endometrial and breast cancers, a down-regulation of LGALS3 is associated with amplified
aggressiveness while in pancreatic cancer, LGALS3 up-regulation is linked to cancer cell
proliferation and invasion [102-104]. A study utilizing LGALS3 small interfering RNA (siRNA)
found the knockdown resulted in a reduction in migration of cancer cells, invasion, cell
proliferation, anchorage-independent colony formation, and tumor growth in mice with prostate
cancer [105]. Signaling pathways of LGALS3 vary between cancers as well. Research has shown
in cases of melanoma and gastric cancer, LGALS3 promotes tumor growth through the upregulation of metalloproteinase-1 (MMP-1) and by the regulation of mitogen-activated protein
kinases (MAPK) pathway in lung cancer [41, 106, 107]. In human breast cancer, LGALS3 has
been shown to activate wingless-related integration site (Wnt) signaling, which is characterized
by nuclear accumulation of β-catenin—a major component of the Wnt pathway [108-110]. In
human colon cancer cells, via the phosphatidylinositol 3-kinase (PI3K) and protein kinase B
(AKT) pathway, LGALS3 regulates glycogen synthase kinase-3β (GSK-3β) phosphorylation
leading to the degradation of β-catenin [108].
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Expression of LGALS3 in myocardial cells of healthy humans and rodents is low,
however, LGALS3 protein up-regulation has been observed during cardiac stressors leading to
cardiac fibrosis and ultimately, heart failure [111]. Expression levels are found to correlate with
progression and severity of cardiac damage, therefore, levels are utilized as a biomarker for heart
failure [112]. It is hypothesized that LGALS3 expression in heart failure is triggered hormonally
by aldosterone or angiotensin II. Also, the combination of LGALS3 and aldosterone or
angiotensin II instigates sclerosis, fibrosis, and hypertrophy of the renal system, cardiac tissue, as
well as vascular tissue [113, 114]. Cardiac fibroblast proliferation is triggered by LGALS3 which
induces detrimental collagen I deposition that will impact the diastolic and systolic functions of
the heart [99].
Galectin-3 in Reproduction
Recently, LGALS3 was identified to play an important part in the preparation of the
endometrium for implantation with a presence in the endometrium and trophoblast cells. Given
the resemblances of tumor invasion and the migration of trophoblast cells, investigators have
addressed the possible roles of LGALS3 at the maternal-fetal interface regarding implantation
[115, 116]. Previous work suggests LGALS3 expression is regulated by different mechanisms in
placental tissues compared to uterine expression. After conducting immunohistochemistry (IHC)
studies on pregnant murine uteroplacental tissue samples, it was concluded that LGALS3 is
synthesized by all cell types within the murine uteroplacental samples. Levels of LGALS3
mRNA remained constant in murine uterine tissues until d12 of gestation and declined thereafter
until parturition. Interestingly, in placental tissues, LGALS3 mRNA levels remained constant
after d12 of gestation until term [115]. In bovine tissues, LGALS3 protein has been identified in
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the cervix, oviduct, uterus, atretic follicles, and CL [117]. Specifically, in the nonpregnant
bovine uterus, LGALS3 has been localized via IHC in some epithelial cells as well as
macrophages located in the submucosa but were absent in endometrial glands [117]. In the
bovine CL, LGALS3 expression was elevated at the regressed state in comparison to all other
luteal stages and was localized on steroidogenic cells in the CL [118].
Successful implantation or attachment requires tight regulation of endometrial receptivity
preparations including cellular proliferation proceeded by differentiation [119]. The expression
of cell surface molecules alters as uterine receptivity develops though not a lot is known about
molecular interactions occurring at the maternal-fetal interface. Galectins have been found to
increase cell-adhesion by associating surface glycoproteins on opposing cells in addition to
strengthening other intercellular adhesion molecules [120].
The Role of Galectin-3 in Apoptosis
A study utilizing the human epithelial endometrial derived cell line, RL95-2, addressed
the effects of intracellular LGALS3 on apoptosis. Apoptosis inducers were utilized to determine
if expression levels of LGALS3 were altered and it was found LGALS3 expression was increased
in apoptotic conditions [6]. To address whether the upregulation of LGALS3 was pro-apoptotic, a
siRNA technique was used to silence LGALS3 in RL95-2 epithelial cells. It was observed that in
the presence of apoptosis inducers, RL95-2 cells with LGALS3 siRNA were more sensitive to the
induced apoptosis. It was then suggested that the upregulation of LGALS3 during the time of
implantation in the human menstrual cycle may result in endometrial antiapoptotic effects [6]. In
addition, LGALS3 was postulated to be an antiapoptotic factor under P4 and E2 regulation. When
RL95-2 cells were treated with LGALS3 siRNA, the previously exhibited antiapoptotic roles of
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P4 and E2 were eliminated. Through an underdetermined relationship, P4 and E2 are proposed to
indirectly or directly promote LGALS3 expression and, consequently, antiapoptotic effects [6].
Further, when studying women with endometriosis, decreased endometrial LGALS3 expression
was observed while P4 and E2 regulated LGALS3 expression in endometrial epithelial cells.
Ultimately, the lack of LGALS3 expression was thought to have caused resistance to a P4 uterine
environment leading to endometriosis-related infertility [121].
Integrins are significant during the preimplantation period as they play a major role in
cell adhesion. Via surface interactions with extracellular matrix ligands, integrins have been
found to play a role in the embryo-endometrium cross talk in humans [122, 123]. Extracellular
LGALS3 binds to β-1 integrin and induces apoptosis. Bovine luteal cells express β-1 integrin and
contain glycans to which LGALS3 will bind. Hashiba et al. (2014) found that PGF stimulated
secreted LGALS3 from cultured luteal steroidogenic cells and LGALS3 plays a structural
luteolytic role through binding to β-1 integrin [118]. Induced by LGALS3, a form of
programmed cell death, termed anoikis, occurs in the bovine luteal steroidogenic cells due to
inhibition of β-1 integrin-extracellular matrix binding [118, 124, 125].
3D Cell Culture
In the past, two-dimensional (2D) monoculture techniques have been utilized to
investigate cellular processes of bovine epithelial and fibroblast cells [126]. To better simulate
the columnar arrangement of epithelial cells in vivo, a three-dimensional (3D) culture allows
epithelial cells to maintain a physiological polarity in vitro due to tight junctions unlike the
traditional 2D cell culture techniques [127, 128]. Tight junctions are imperative to epithelial
cellular functions because the passage of ions and molecules paracellularly is regulated by tight
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junctions [129, 130]. The 3D transwell culture system enables the coculture of two cells types
which physiologically interact in vivo. Transepithelial electrical resistance (TEER), a
measurement which reflects epithelial integrity, can be measured via an epithelial volt-ohm
meter [127]. The following studies investigated the expression of galectins in bovine conceptuses
and in the endometrium. Further, the effect of IFNT and LGALS3 on the endometrial epithelium
and fibroblast transcriptomes in a 3D cell culture system was investigated.
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CHAPTER TWO
GALECTIN GENE EXPRESSION IN BOVINE AND OVINE ELONGATING
CONCEPTUSES AND PREGNANT AND CYCLIC ENDOMETRIUM

ABSTRACT

Pregnancy loss in cattle is greatest in the first 30 days of gestation. Near d15 of gestation,
bovine conceptuses elongate and express LGALS1, an immunosuppressive glycan-binding
protein believed to be essential for implantation. However, other members of the bovine galectin
family, including LGALS3, LGALS4, LGALS7, LGALS8, LGALS9 and a galectin-13-like gene
(LGALS13L), also may be expressed by the elongating conceptus. Therefore, galectin expression
in elongating, d16 bovine conceptuses and intercaruncular endometrium as well as elongating,
d14 ovine conceptuses and intercaruncular endometrium was assessed by RT-qPCR. Angus
heifer and Texel ewes underwent estrous cycle synchronization and either inseminated or not
bred. On d16 (heifers) or d14 (ewes) after synchronized estrus (d0), reproductive tracts of
pregnant (heifers, n=4; ewes, n=3) and cyclic (heifers, n=4; ewes, n=3) animals were removed.
Conceptuses and intercaruncular endometrial samples were then collected. Conceptuses and
intercaruncular endometrium samples were individually snap frozen and stored at -80°C until
RT-qPCR. Bovine and ovine conceptus gene expression was normalized to control genes
GAPDH and YWHAZ, and endometrial gene expression was normalized to control genes H3F3A
and RNF11. A general linear model procedure (PROC GLM) in SAS was used to test for
differences. For the conceptus data, alpha was set at 0.05, and a Tukey’s test was included in the
analysis. Conceptus data are presented as non-transformed means ± standard deviation (SD) of
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the mean. Endometrial data are presented as non-transformed least square means (LSM) ±
standard error of the mean (SEM) and P ≤ 0.05 was considered significant. In bovine
conceptuses, expression of LGALS3 (24.47 ± 6.41) and LGALS1 (21.80 ± 2.07) was similar, yet,
greater than all other galectins measured (α = 0.05). Expression of LGALS8 (1.73 ± 0.27) was
12-fold less than LGALS1, however, LGALS8 expression was greater than LGALS9 (0.77 ± 0.77),
LGALS13L (0.30 ± 0.10), LGALS4 (0.08 ± 0.01) and LGALS7 (0.02 ± 0.01) (α = 0.05). In bovine
intercaruncular endometrium, expression of LGALS1, LGALS8, and LGALS9 were greatest.
Compared to cyclic heifers, endometrial expression of LGALS7 was less (5.80 ± 2.35 and 2.62 ±
2.35; cyclic and pregnant, respectively; P ≤ 0.05), while expression of LGALS9 (9.26 ± 2.25 and
24.56 ± 2.25; cyclic and pregnant, respectively; P ≤ 0.001) and LGALS3 were greater (2.62 ±
0.52 and 4.40 ± 0.52; cyclic and pregnant, respectively; P ≤ 0.05) during pregnancy. In sheep
conceptuses, expression of LGALS3 (4.30 ± 0.78), LGALS1 (1.90 ± 0.25) and LGALS8 (1.68 ±
0.25) were similar. Compared to all other galectins measured, LGALS4 (0.20 ± 0.10) had the
lowest level of expression (α = 0.05). In ovine intercaruncular endometrium, expression of
LGALS3, LGALS8, and LGALS15 were greatest. Compared to cyclic ewes, expression of
LGALS7 was greater in pregnant ewes (0.81 ± 0.24 and 2.25 ± 0.24; cyclic and pregnant,
respectively; P ≤ 0.05) while LGALS4 (3.10 ± 0.38 and 1.78 ± 0.38; cyclic and pregnant,
respectively; P = 0.06) tended to be less during pregnancy and LGALS15 tended to be greater
during pregnancy (104.30 ± 234.20 and 591.35 ± 234.20, P = 0.07; cyclic and pregnant,
respectively). In conclusion, elongating bovine and ovine conceptuses express various members
of the galectin gene family, and select galectin genes are differentially expressed in the
endometrium during pregnancy. The galectins may have important functions during early
pregnancy in ruminants.
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INTRODUCTION

Galectins are a large family of -galactoside-binding animal lectins that have numerous
physiological functions. Lectins bind carbohydrates and result in cell agglutination while playing
vital roles in pathogen defense, cell trafficking, and immune regulation [82, 83]. Currently, 15
members of the galectin family have been identified in mammals [84]. Galectins are ancient
members of a lectin family, which are characterized by having conserved amino acid sequences
with at least one CRD and the ability to recognize -galactoside structures on cell surface
glycoconjugates [85, 86]. Galectins also interact with proteins independently of carbohydrates—
acting in an autocrine manner to inhibit cell growth and division [133]. The galectin family of
proteins has been shown to play a crucial role in regulating tumor and placental angiogenesis
[134, 135]. In addition, galectins play a large role immunologically in inflammation, adaptive
and innate immune responses, and immune tolerance [136, 137]. Elongating bovine conceptuses
express galectin-1 (LGALS1) which has also been associated with the viability of d7 bovine
blastocysts. Expression of LGALS1 was found to be elevated in in-vivo produced blastocysts
compared to less viable in-vitro produced d7 bovine blastocysts [138]. Further, the endometrium
of sheep produces LGALS15 after d10 of gestation to aid in trophectoderm migration and
attachment. However, LGALS15 is not found in cattle [64].
Galectin family members have been categorized into three groups based on the number and
organization of CRDs present. The prototype group, consisting of a single CRD, includes
LGALS1, 2, 5, 7, 10, 11, 13, 14, and 15. The chimera type group, whose only member is
LGALS3, consists of one CRD along with a non-lectin domain. The tandem repeat group, which
include a short peptide linked by two CRDs, members include LGALS4, 6, 8, 9, and 12 [82, 87,
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88]. According to published transcriptomic and proteomic data and published bovine genome
sequences in NCBI, cattle have genes encoding LGALS1, galectin-2 (LGALS2), LGALS3,
galectin-4 (LGALS4), galectin-7 (LGALS7), galectin 7B (LGALS7B), galectin-8 (LGALS8),
LGALS9, galectin-12 (LGALS12), and galectin-13Like (LGALS13L) while the ovine genome
contains galectin genes for LGALS1, LGALS2, LGALS3, LGALS4, LGALS7, LGALS8, LGALS9,
LGALS12, galectin-14 (LGALS14), and LGALS15 (https://www.ncbi.nlm.nih.gov/genbank/
version 19.12.2017, 23.30.00).
Alterations of the uterine environment, including histotroph gene expression, are
mediated by an increased concentration of P4 which promotes rapid conceptus growth [23].
Uterine histotroph consists of enzymes, growth factors, cytokines, hormones, transport proteins,
and other substances [20, 24-27]. The bovine conceptus will double in length every day between
d9-16 of gestation [19-21]. Bovine pre-attachment blastocysts are characterized by having a
filamentous and thread-like structure, which arises around d16-17 [22]. The conceptus will span
both uterine horns by d18 of gestation, later attaching to the uterine surface [7]. Early
conceptuses secrete factors, including proteins and steroids, that aid in alteration of the maternal
endometrium [131, 132].
The aim of this study was to characterize galectin gene expression in the early bovine and
ovine conceptus during the elongation phase of development as well as to characterize their
expression in the endometrium in response to the conceptus.
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MATERIALS AND METHODS
Animals and Tissue Collection
All procedures were in compliance with the Guide for the Care and Use of Agricultural
Animals in Research and Teaching and approved by the West Virginia University Institutional
Animal Care and Use Committee (WVU IACUC). All animals were housed at the West Virginia
University Animal Science Farm (Morgantown, WV). Angus and Hereford heifers were
subjected to a Co-Sync + 7d controlled intravaginal drug releasing device (CIDR; Zoetis,
Parsippany-Troy Hills, NJ) protocol to synchronize estrus [139]. Approximately 52-56 h post
CIDR removal, heifers received GnRH and were either inseminated (n=4) with semen from an
Angus bull or not bred (n=4). Estrus was synchronized in Texel ewes using a 5d CIDR program
[140]. Ewes were then either placed with a Texel ram to be naturally bred (n=3) or not placed
with the ram (n=3) 24 hours after CIDR removal. To obtain pregnant and cyclic reproductive
tissues, heifers and ewes were slaughtered at a local abattoir 16 and 14 days later, respectively.
Within 45 min, all reproductive tracts were flushed using 20 mL of 1X PBS (Thermo Fisher,
Waltham, MA). Conceptuses were then collected and intercaruncular endometrial samples were
collected from the uterine horn ipsilateral to the CL. All tissue samples were immediately snapfrozen and stored at -80˚C until RNA extraction.

RNA Extraction
RNA was extracted from bovine (n=4) and ovine (n=3) conceptuses and endometrium. A
5-mm steel bead (Qiagen, Hilden, Germany), washed in RNaseZap (Thermo Fisher), was placed
in each screw-cap tube containing the conceptus along with 350 µL of lysis buffer. Screw-cap
tubes were placed in a Mini-Beadbeater-24 (Biospec Products, Bartlesville, Oklahoma) and
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homogenized for 30 s at maximum speed. The lysate was transferred to a homogenizer spin
column (Omega Bio-Tek, Inc., Norcross, GA) along with an additional 350 µL of lysis buffer.
Columns were centrifuged for 2 min at maximum speed. The RNA was extracted from the lysate
according to recommendations from the manufacturer of the E.Z.N.A. DNA/RNA kit (Omega
Bio-Tek, Inc.).
Intercaruncular endometrium samples (<50 mg) were placed in a screw-cap tube
containing a single steel bead (Qiagen) and 1.0 mL of Trizol (Thermo Fisher). Screw-cap tubes
were then placed in a Mini-Beadbeater-24 (Biospec Products) and homogenized for 2 min at
maximum speed. After centrifuging, 0.1 mL of chloroform was added to the lysate, vigorously
shaken, and allowed to rest for 3 min. Samples were then transferred to a precooled centrifuge
(4°C) and spun at 12,000 x g for 15 min. The aqueous supernatant from the tubes was removed,
combined with 1.5 x volumes of 100% ethanol, and gently mixed. The E.Z.N.A Total RNA Kit 1
(Omega Bio-Tek, Inc.) was then used to extract RNA following the manufacturer's
recommendations. The concentration of RNA and integrity was determined using NanoDrop
(NanoDrop ND-1000, NanoDrop Technologies, Wilmington, DE) and Bioanalyzer (2100
Bioanalyzer, Agilent Technologies, Santa Clara, CA). The RNA was stored at -80°C until cDNA
was synthesized.

Reverse Transcription and RT-qPCR
Following the manufacturer's recommendations, cDNA was synthesized using a High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Briefly, 500
ng of RNA and nuclease-free water was added to 10 µL of master mix to reach a total volume of
20 µL. No-reverse transcriptase control samples were prepared. Following a 2 h cDNA synthesis
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at 37˚C, 5 µL of each sample was pooled and the remaining cDNA was diluted 1:20 using
nuclease-free water. Pooled cDNA was used to generate 7 standards (1:4 serial dilutions).
Standards were used to calculate primer efficiencies (E = [10(-1/slope)-1). The slope is a plot of
observed Ct values versus the 7 standard serial dilutions. Percent efficiency was then obtained by
dividing E by 2 and multiplying by 100.
Quantitative real-time PCR was utilized to measure the expression of galectin genes. The
CFX96 Real-Time PCR machine (Bio-Rad Laboratories, Hercules, CA) was used to perform
RT-qPCR reactions. All primers were designed using Primer3Plus (Version 2.4.2) unless
otherwise noted. Primer sets for bovine and ovine cDNA were identical unless otherwise noted.
Sample RT-qPCR reactions were carried out in 20 L reactions in duplicate [10 L of SYBR
Green Master Mix (Catalog Number: A25743; Applied Biosystems), 1.2 L of forward and
reverse primer mix (1 µM final concentration), 2.6 L nuclease-free water, and 5L of cDNA
template (6.6 ng RNA equivalent)]. RT-qPCR reaction of no-reverse transcriptase controls and
no-template controls were included. Thermo-cycling conditions were as follows: 50°C for 2 min,
95°C for 2 min, which was followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. A
disassociation analysis was included for each primer set and the presence of a single, sharp peak
was confirmed.
The qbase+ package (Biogazelle; Zwijnaarde, Belgium) was used to select reference
genes. Average RT-qPCR Ct values were imported into qbase+ software, which was used to
analyze real-time data and generate the normalized relative quantity (NRQ) of genes of interest
using a generalized delta-delta quantification cycle method (ΔΔCq; also known as ΔΔ cycle
threshold (Ct))[141]. A panel of eight prospective reference genes was analyzed (GAPDH,
ACTB, RPL18, PPIA, YWHAZ, RNF11, H3F3A, SDHA) across all conceptus cDNA samples and
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a subset of 12 endometrium cDNA samples. Appropriate reference genes were selected using the
qbase+ geNorm function [141]. Bovine and ovine conceptus target gene expression was
normalized to two housekeeping genes, glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ)
(geNorm M ≤ 0.5). The endometrial expression for both heifers and ewes was normalized to ring
finger protein 11 (RNF11) and H3 histone family member 3A (H3F3A) (geNorm M ≤ 0.5) [142].
Conceptus and endometrium gene expression was calculated using the following equation:
Relative quantity (RQ) = 2 (35-Ct). The RQ values were divided by the normalization factor
(geometric mean of control gene RQ) to obtain the normalized relative quantity (NRQ). The
NRQ values were then multiplied by a factor of 100. RT-qPCR amplicon size was validated
using gel electrophoresis (0.8% agarose gel, 1X Tris/Borate/EDTA Buffer, and 0.5 µg/mL
ethidium bromide) and a 50 bp DNA ladder (New England BioLabs, Ipswich, MA). Gels were
visualized under ultra-violet (UV) light using the DigiDoc-It Imaging System (Analytik Jena,
Jena, Germany). Amplicons from RT-qPCR on cDNA from conceptuses were visualized using
gel electrophoresis to ensure primer specificity (Figure 2.3).

Immunohistochemistry
An elongating d15 bovine conceptus was obtained during a previous study [143]. After
flushing the conceptus from the reproductive tract, the conceptus was placed in 4% buffered
formalin phosphate (Thermo-Fisher) overnight and embedded in 2% agarose before processing.
Conceptuses were then embedded in paraffin and sections (4 m) were mounted on microscope
slides which were deparaffinized using xylene, and were rehydrated through a series of EtOH
washes, and boiled for 6 min in 0.01M sodium citrate buffer as an epitope retrieval technique.
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Slides were allowed to cool for 45 min on ice and then were washed twice for 5 min in 1 X PBS.
The tissue on slides was then enclosed using a wax pen and sections were incubated in 0.3%
hydrogen peroxide in methanol for 30 min to block endogenous peroxidase activity. Slides were
washed in 1 X PBS for 5 min and then blocking serum provided with the Rabbit IgG Vectastain
Elite ABC-Peroxidase Kit (Cat. Number: PK-6101, Vector Laboratories, Inc., Burlington, CA)
was added to each slide for 20 min to block non-specific binding. Slides were rinsed with 1 X
PBS and then the Streptavidin/Biotin Blocking Kit (Vector Laboratories, Inc.) was used to block
endogenous streptavidin and biotin. Following a rinse with 1 X PBS, slides were incubated with
StartingBlock (PBS) Blocking buffer (Thermo Fisher) for 30 min. A primary rabbit anti-bovine
polyclonal antibody (SAB2101338, Sigma Aldrich, St. Louis, MO) directed towards the N
terminal region of LGALS3, was diluted in 1 X PBS (1:500) and 500 L of the solution was
added to a serial section of the conceptus. Rabbit IgG, at the same concentration as the primary
antibody, was used as an antibody control and 500 L added to IgG control slides at the same
concentration as the primary antibody. The primary antibody and antibody control were left on
slides overnight at 4C. The following morning, a biotinylated secondary antibody, included in
the Vectastain Elite ABC-Peroxidase Kit, was added to slides according to the manufacturer's
recommendations. Following a 30 min incubation with the secondary antibody solution, slides
were rinsed with 1 X PBS for 15 min. Slides were then covered with Vectastain Elite ABC
reagent for 30 min and once again, rinsed with 1 X PBS for 15 min. ImmPACT DAB peroxidase
substrate (SK-4105, Vector Laboratories) was added to tissue sections and allowed to incubate
for 2-5 min. Sections were rinsed in running tap water for 5 min followed by 9 seconds in
hematoxylin (GH5216, Sigma Aldrich). Sections were immediately rinsed with double distilled
water for 2 min. Slides were then dipped in Scott’s tap water and placed in double distilled
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water. Slides were dehydrated in graded alcohol followed by xylene. Coverslips were mounted
over tissues using Permount (Thermo Fisher) and images were taken using a Zeiss Axio Lab.A1
microscope (Zeiss, Oberkochen, Germany).

Statistical Analysis
Relative expression data were analyzed using the general linear model procedure (PROC
GLM) in the statistical analysis software (SAS Institute Inc.; Cary, NC). For the conceptuses, the
analyses tested for differences in relative galectin family members. For the endometrium, the
analysis tested for an effect of pregnancy status on gene expression of select galectin family
members. All data were log base 10 transformed. Conceptus data are presented as the nontransformed means ± standard deviation of the mean (SD). Alpha was set at 0.05 and a Tukey’s
test was included in the analysis of conceptus gene expression. Endometrial data are presented as
non-transformed least squares means (LSM) ± standard error of the mean (SEM). P-values
represent the transformed data and P ≤ 0.05 was considered significant.

RESULTS

According to GenBank, LGALS1, 2, 3, 4, 7, 8, 9, 12, and 13like are present in the bovine
genome while genes for LGALS1, 2, 3, 4, 7, 8, 9, 12, 14, and 15 are listed as being present in the
ovine genome in GenBank. Therefore, we investigated the expression of galectins in elongating
bovine and ovine conceptuses and pregnant and cyclic intercaruncular endometrium.
Representative images of elongating bovine and ovine conceptuses obtained are shown in Figure
2.2.
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Bovine Day 16 Conceptus and Endometrium Galectin Gene Expression
The expression of IFNT was investigated via RT-qPCR in d16 elongating bovine
conceptuses (1293.24 ± 420.87; mean ± SD) as well as the third-most stable reference gene,
H3F3A (78.91 ± 17.19; mean ± SD). Expression of galectins in d16 bovine conceptuses, depicted
in Figure 2.3, were found to include LGALS1 (21.80 ± 2.07; mean ± SD), LGALS3 (24.47 ± 6.41;
mean ± SD), LGALS4 (0.08 ± 0.01; mean ± SD), LGALS7 (0.02 ± 0.01; mean ± SD), LGALS7B
(0.01 ± 0.005; mean ± SD), LGALS8 (1.73 ± 0.27; mean ± SD), LGALS9 (0.77 ± 0.77; mean ±
SD), and LGALS13L (0.29 ± 0.10; mean ± SD).
Intercaruncular endometrium of pregnant and cyclic heifers expressed LGALS1 (25.66 ±
2.15 and 30.10 ± 2.15; cyclic and pregnant, respectively; LSM ± SEM), LGALS3 (2.62 ± 0.52
and 4.40 ± 0.52; cyclic and pregnant, respectively; LSM ± SEM; P ≤ 0.05), LGALS4 (5.47 ± 0.66
and 4.64 ± 0.66; cyclic and pregnant, respectively; LSM ± SEM), LGALS7 (5.80 ± 2.35 and 2.62
± 2.35; cyclic and pregnant, respectively; LSM ± SEM; P ≤ 0.05), LGALS7B (5.04 ± 2.59 and
10.04 ± 2.59; cyclic and pregnant, respectively; LSM ± SEM), LGALS8 (21.01 ± 3.95 and 25.24
± 3.95; cyclic and pregnant, respectively; LSM ± SEM), LGALS9 (9.26 ± 2.25 and 24.56 ± 2.25;
cyclic and pregnant, respectively; LSM ± SEM; P ≤ 0.001), and LGALS13L (0.24 ± 0.07 and
0.14 ± 0.07; cyclic and pregnant, respectively; LSM ± SEM) (Figure 2.4). Expression of
LGALS1, LGALS8, and LGALS9 were greatest. Compared to cyclic heifers, endometrial
expression of LGALS7 was less (5.80 ± 2.35 and 2.62 ± 2.35; cyclic and pregnant, respectively;
LSM ± SEM; P ≤ 0.05), while expression of LGALS9 (9.26 ± 2.25 and 24.56 ± 2.25; cyclic and
pregnant, respectively; LSM ± SEM; P ≤ 0.001) and LGALS3 were greater (2.62 ± 0.52 and 4.40
± 0.52; cyclic and pregnant, respectively; LSM ± SEM; P ≤ 0.05) during pregnancy.
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Ovine Day 14 Conceptus and Endometrium Galectin Gene Expression
We were unable to detect gene expression of LGALS2 and LGALS12 in the ovine
elongating conceptuses nor the endometrium of pregnant and cyclic ewes which could be due to
primer sets that were not efficient or the tissue did not express these genes. The expression of
IFNT was investigated via RT-qPCR in d14 elongating ovine conceptuses (Figure 2.5; 3296.74 ±
1090.66; mean ± SD) as well as the third-most stable reference gene, H3F3A (35.71 ± 1.43;
mean ± SD). Expression of galectins in d14 ovine conceptuses, depicted in Figure 2.5, was found
to include LGALS1 (1.90 ± 0.25; mean ± SD), LGALS3 (4.30 ± 0.78; mean ± SD), LGALS4 (0.19
± 0.10; mean ± SD), LGALS7 (0.04 ± 0.02; mean ± SD), LGALS8 (1.68 ± 0.25; mean ± SD), and
LGALS13L (1.33 ± 1.09; mean ± SD).
Intercaruncular endometrium of pregnant and cyclic ewes expressed LGALS1 (0.83 ±
0.21 and 0.50 ± 0.21; cyclic and pregnant, respectively; LSM ± SEM), LGALS3 (7.60 ± 1.94 and
12.36 ± 1.94; cyclic and pregnant, respectively; LSM ± SEM), LGALS4 (3.10 ± 0.38 and 1.78 ±
0.38; cyclic and pregnant, respectively; LSM ± SEM; P = 0.06), LGALS7 (0.81 ± 0.24 and 2.25
± 0.24; cyclic and pregnant, respectively; LSM ± SEM; P ≤ 0.05), LGALS8 (72.84 ± 17.45 and
96.60 ± 17.45; cyclic and pregnant, respectively; LSM ± SEM), and LGALS15 (104.30 ± 234.20
and 591.35 ± 234.20; cyclic and pregnant, respectively; LSM ± SEM; P = 0.07) (Figure 2.6).
Expression of LGALS3, LGALS8, and LGALS15 were greatest. Compared to cyclic ewes,
expression of LGALS7 was greater in pregnant ewes (0.81 ± 0.24 and 2.25 ± 0.24; cyclic and
pregnant, respectively; LSM ± SEM; P ≤ 0.05) while LGALS4 (3.10 ± 0.38 and 1.78 ± 0.38;
cyclic and pregnant, respectively; LSM ± SEM; P = 0.06) tended to be less during pregnancy and
LGALS15 tended to be greater during pregnancy (104.30 ± 234.20 and 591.35 ± 234.20; LSM ±
SEM; P = 0.07; cyclic and pregnant, respectively).
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Localization of LGALS3 Protein in an Elongating Bovine Conceptus
The presence and localization of LGALS3 protein was investigated in a d15 elongating
bovine conceptus. Figure 2.8 exhibits staining of LGALS3 protein in the bovine conceptus but
not in the isotype control slide, rabbit IgG. Staining appeared to be within both the
trophectoderm and endoderm cytoplasm.

DISCUSSION

Galectins have been suggested to play roles in the regulation of tumors and placental
angiogenesis, and an immunological role through the regulation of inflammation, adaptive and
innate immune responses, and immune tolerance [134-137]. Successful implantation or
attachment requires tight regulation of endometrial receptivity preparations including cellular
proliferation preceded by differentiation [119]. The expression profile of cell surface molecules
alters as uterine receptivity develops. Galectins have been found to increase cell-adhesion by
associating surface glycoproteins on opposing cells in addition to strengthening other
intercellular adhesion molecules [120]. Galectins have been highly researched in human and
mice reproductive biology. The role of many galectins during bovine and ovine pregnancy is
currently undetermined. In this study, we aimed to better characterize galectin genes expressed
by the early bovine and ovine conceptus during the elongation phase of development as well as
to characterize their expression in the endometrium during pregnancy.
We were unable to detect gene expression of LGALS2 and LGALS12 in the bovine
elongating conceptuses nor the endometrium of pregnant and cyclic animals which could be due
to primer sets that were not efficient or the tissue did not express these genes. Early bovine
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conceptuses have been previously reported to express LGALS1 [144]. Data from the current
study suggest that both the bovine and ovine elongating conceptuses express LGALS1. Bovine
endometrial expression of LGALS1 was greater than any other galectin investigated; however,
expression was not affected by pregnancy status which supports previously published data by
Okumu et al. (2013) [138]. Tirado-González et al. (2013) reported systemic levels of LGALS1
were elevated during the first trimester of normal human pregnancy compared to women who
subsequently suffered a miscarriage, and they suggested that circulating LGALS1 could serve as
an indicator of early successful pregnancy in humans. Their results supported that LGALS1 is
playing an immunoregulatory role during pregnancy through the modulation of human leukocyte
antigen G expressed on trophoblast cells [145]. Expression of LGALS1 also has been associated
with migration of trophoblast stem cells as the knockout of LGALS1 in trophoblast stem cells
resulted in the down-regulation of matrix metalloproteinases (MMPs), which are associated with
successful cytotrophoblast invasion. Overexpression of LGALS1 resulted in the up-regulation of
MMPs. Pre-eclampsia patients have a higher placental expression of LGALS1 than normal
patients suggesting that expression of LGALS1 is a fetal response to elevated maternal systemic
inflammation. Therefore, LGALS1 was suggested to play a role in human maternal-fetal immune
tolerance [147].
Investigators have addressed the possible roles of LGALS3 at the maternal-fetal interface
[115, 116]. Bovine and ovine embryos both expressed LGALS3 at d16 and d14, respectively.
Okumu et al. (2011) published that endometrial LGALS3 expression was not different in
pregnant and cyclic heifers [138]. Data from the current study suggest expression of LGALS3 is
higher in the endometrium of pregnant heifers. Previous work suggests LGALS3 expression is
regulated by different mechanisms in placental tissues compared to in the uterus. After
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conducting immunohistochemistry (IHC) studies on pregnant murine uteroplacental tissue
samples, it was concluded that LGALS3 is synthesized by all cell types within the murine
uteroplacental samples. Levels of LGALS3 mRNA remained constant in murine uterine tissues
until d12 of gestation and declined thereafter until parturition. Interestingly, in placental tissues,
LGALS3 mRNA levels remained constant after d12 of gestation until term [115]. In bovine
tissues, LGALS3 protein has been identified in the cervix, oviduct, uterus, atretic follicles, and
CL [117]. Specifically, in the nonpregnant bovine uterus, LGALS3 has been localized via IHC in
epithelial cells as well as macrophages located in the submucosa but absent in endometrial
glands [117]. In the bovine CL, LGALS3 expression was elevated at the regressed state in
comparison to all other luteal stages and was localized on steroidogenic cells in the CL [118].
In addition to LGALS1 and LGALS3, d16 bovine conceptuses expressed LGALS8,
LGALS9, and LGALS13 while expression of LGALS4, LGALS7, and LGALS7B was minimal.
Expression of LGALS4 and LGALS7B was detected in the bovine endometrium; however, neither
was affected by pregnancy status. Pregnancy increased endometrial expression of LGALS9. The
endometrium of cyclic heifers expressed greater LGALS7 in comparison to pregnant animals.
First-trimester human placentas express LGALS7 and LGALS7 might play a role in adhesion
during early pregnancy [148]. In addition, LGALS7 was elevated from weeks 10-12 and 17-20 in
the serum of women who developed pre-eclampsia later on in pregnancy [149].
Interestingly, LGALS8 expression in the bovine endometrium was similar to that of
LGALS1 and LGALS9. In addition, expression of LGALS8 was detected in ovine conceptuses and
endometrial samples. Though the functions of LGALS8 during early pregnancy have not been
fully elucidated, LGALS8 was expressed in similar patterns to LGALS1 and LGALS3 in the
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human trophoblast during the first trimester [150]. In humans, uterodomes form on the plasma
membrane during the window of implantation (mid-secretory phase) to allow for the blastocyst
to implant, and LGALS9 was highly expressed by uterodomes during this timeframe, suggesting
LGALS9 could serve as an endometrial marker of receptivity [151].
Specifically expressed in sheep, endometrial LGALS15 has been hypothesized to be a
regulator of blastocyst and trophoblast development. In addition to endometrial LGALS15 in
sheep, the d14 ovine conceptus expressed LGALS15. Past research reports that the treatment of
ovine trophectoderm cells with LGALS15 resulted in increased proliferation and migration.
Through integrin binding, LGALS15 aids in the attachment and migration of the trophectoderm
[64].
CONCLUSIONS
Collectively, findings from this study confirm that various galectins are present in the
elongating ruminant embryo and are differentially expressed by the endometrium during early
pregnancy. Previous research on human and mice tissue has noted that the dysregulation of
galectins leads to abnormal pregnancies and infertility [152]. As little research has focused on
galectins in ruminant reproduction, future research should focus on characterizing the functions
of specific galectins during early pregnancy in ruminants.
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Table 2.1. GenBank accession number, gene name, primer direction, primer sequence, product size and percent amplification
efficiency of cDNAs amplified during real time quantitative-polymerase chain reaction (RT-qPCR).
Bovine
GenBank
Acc. Number

Ovine
GenBank
Acc. Number

Gene

Primer

Primer Sequence (5’-3’)

Product
Size
(bp)

Bovine
Amp.
Efficiency

Ovine
Amp.
Efficiency

Source

NM_175782.1

NM_001009287.1

LGALS1

Forward

GTGGCCGCAGACGCCAAGAG

99

90%

90%

[143]

Reverse
Forward
Reverse

ACGTCCCCATGCGCGTTGAAA
CAGTGCAGAGGCGTCGGGAAA
CTGCCCCAGCAGGCTGGTTT

121

97%

99%

This Study

TCATGGTCATGACGGAGCACTTCA
ATTGAAGCATCAGGTCGCCATCCA
CTTTAACGTCCCCCACAAGA
ATCACTGCCTGGTTCCTCAC
GAGCTTTAATGTCCCCCACA

127

106%

107%

This Study

136

102%

104%

This Study

NM_001102341.2

XM_004010664.4

LGALS3

NM_001034768.2

XM_027978255.1

LGALS4

XM_002694975.5

XM_004015233.4

LGALS7

XM_002694977.4

---

LGALS7B

Forward
Reverse
Forward
Reverse
Forward

139

101%

---

This Study

LGALS8*

Reverse
Forward

ATCACTGCCTGGTTCCTCAC
TCGTGATCATGGTCCTGAAA

141

96%

98%

This Study

Reverse
Forward

TGAAGCCCACAGAGTGAATG
TCAGCTTCCAGCCTCCAGGG

86

96%

93%

[153]

Reverse
Forward
Reverse
Forward
Reverse
Forward

TCCAGGGGCGCTGTGTATGGT
GGTGGATTTCGGCACTGGTA
TCCCGTCCGTGAAAGTGTTC
GGTGGATTTCTGCACGGGTA
ATCACCACCATGCTGTTCGT
TGCAGGACAGAAAAGACTTTGGT

98

---

93%

This Study

81

97%

---

This Study

69

91%

91%

[154]

Reverse

CCTGATCCTTCTGGAGCTGG

NM_001045954.2

XM_027962309.1

NM_001015570.3

XM_004012486.3

LGALS9

---

NM_001009238.1

LGALS15

XM_024979086.1

---

LGALS13L

NM_001168279.1

NM_001123400.1

IFNT

*To amplify ovine LGALS8, a separate forward primer was used with the following sequence (3’-5’): TCGTGATCATGGTGCTG
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Figure 2.1. Images of a d16 bovine (A) and d14 ovine (B) conceptus.
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Figure 2.2. Galectin RT-qPCR products visualized on a 0.8% agarose gel and a 50 bp DNA
ladder. Amplicons for cattle (C) and sheep (S) galectins side by side.
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Figure 2.3. Quantitative real-time PCR analysis of galectins in d16 bovine conceptuses. Data presented are the means ± SD.
Expression of the genes was normalized to the two control genes, GAPDH and YWHAZ. Relative expression of IFNT and the
control gene, H3F3A, are also presented. (a-h) Means with the same letter are not statistically different (α = 0.05).
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Figure 2.4. Quantitative real-time PCR analysis of galectins in pregnant (n=4) and cyclic (n=4) d16 bovine intercaruncular
endometrium. Galectin expression was normalized to two control genes, H3F3A and RNF11. Data are presented as LSM ±
SEM.
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Figure 2.5. Quantitative real-time PCR analysis of galectins in d14 ovine conceptuses. Data presented are the means ± standard
deviation. Expression of the genes was normalized to the two control genes, GAPDH and YWHAZ. Relative expression of
IFNT and the control gene, H3F3A, are also presented. (a-g) Means with the same letter are not significantly different (α =
0.05).
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Figure 2.6. Quantitative real-time PCR analysis of galectins in pregnant (n=3) and cyclic (n=3) d14 ovine intercaruncular
endometrium. Galectin expression is relative to two control genes, H3F3A and RNF11. Data are presented as LSM ± SEM.
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Figure 2.7. (B and D) Galectin-3 (LGALS3) protein in an elongating d15 bovine conceptus. (A
and C) Absence of DAB staining in IgG isotype control serial section of the conceptus.
Images were taken on a Zeiss Axio Lab.A1 microscope at 10 X (A-B) and 20 X (C-D)
magnification.
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CHAPTER THREE

EFFECT OF INTERFERON TAU AND GALECTIN-3 ON BOVINE ENDOMETRIAL
EPITHELIAL AND FIBROBLAST CELL TRANSCRIPTOMES IN 3D CELL CULTURE

ABSTRACT

Interferon-tau (IFNT), secreted by the elongating bovine conceptus, is the maternal
recognition of pregnancy signal that suppresses the endometrial luteolytic mechanism by
modifying expression of genes in specific cell types within the endometrium. The conceptus also
secretes galectin proteins, specifically galectin-3. This study assessed the effect of IFNT
(Experiment 1) and LGALS3 (Experiment 2) on bovine endometrial epithelial and fibroblast cell
transcriptomes when the mid-luteal phase endometrial cells were cultured in a 3D environment.
In Experiment one, epithelial cells, cultured in Transwell inserts above the fibroblast cells, were
treated with RPMI media alone (control; n=4) or treatment media (RPMI with 5% FBS and 1%
ABAM) containing 100 ng of recombinant ovine IFNT (n=3) for 6 h. In Experiment two, cells
were treated with either RPMI media alone (Control; n=5), pregnant ovine uterine flush fluid,
theoretically containing INFT, diluted with treatment media 1:1 (n=4), or treatment media
(RPMI with 5% FBS and 1% ABAM) containing either 100 or 1000 ng of recombinant mouse
LGALS3 (n=5) for 6 h. Total RNA was extracted from both cell types and the transcriptomes
were assayed by RNA Sequencing and RT-qPCR. Interferon-tau regulated 673 and 83 genes
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(differentially expressed genes or DEGs) in epithelial and fibroblast cells, respectively (P ≤
0.001; FDR P ≤ 0.05). Many of the DEGs identified in the epithelial (205) and fibroblast cells
(64) were previously reported as IFNT and bovine conceptus-induced DEGs in intact bovine
endometrium, including well-known ISGs such as ISG15, MX1, MX2, OAS1, and OAS2.
Surprisingly, the ZC3HAV1 gene, which was recently found to be up-regulated in intact bovine
endometrium in response to the conceptus, was only up-regulated in fibroblast cells despite
applying IFNT to the apical surface of the epithelial cells in 3D culture. The RNA-Seq analysis
of the bovine endometrial cells treated with mouse LGALS3 protein resulted in the identification
of a single gene, RPL23A, that was upregulated in epithelial cells treated with 100 ng of
LGALS3 (P ≤ 0.001; FDR P ≤ 0.05). This study supports the idea that the 3D culture of bovine
endometrial cells may be utilized to study early conceptus-maternal crosstalk and identify
endometrial cell type-specific responses to the conceptus.

INTRODUCTION

The beef cow/calf industry experiences an annual loss exceeding $1.2 billion, with the
largest contributing factor being embryonic loss [1]. The highest incidence of pregnancy loss in
cattle occurs during the embryonic period of gestation, with 40% occurring between d8 and d17
[2-4]. Bovine embryos will elongate from approximately 2 mm on d13 into an approximately 6
cm filamentous structure, spanning the length of the uterine horn by d19 [19, 20, 30]. During this
time, the conceptus secretes a substance to communicate to the maternal endometrium its
presence and prolong progesterone (P4) production by the CL [5]. This secretory protein, IFNT,
is derived from the bovine mononuclear trophectoderm. The presence of IFNT stimulates the
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expression of ISGs in addition to blocking the pulsatile secretion of endometrial PGF from the
uterine horn and ultimately, luteolysis [42]. Luteolysis, the functional and structural regression of
the CL, is prevented due to the paracrine release of IFNT from the conceptus which acts to
modify endometrial PGF through the silencing of uterine epithelial cell estrogen receptor alpha
(ESR1) and thus, epithelia oxytocin receptor (OTR) [155]. Overall, luteal P4 is maintained and
supports gestation until the establishment of placental P4.
Interferon-tau is a type I interferon. The type I interferons bind IFNAR to signal a
biological response. There is a single Type II interferon family member, IFNG, which binds the
IFNGR [40]. The IFNT acts on the endometrium and modifies endometrial cell gene expression.
The pregnancy recognition signal, IFNT, affects the differential expression of genes in the LE,
dGE, sGE, and stroma [36, 41]. The genes affected, ISGs, are categorized in two distinct
classifications, classical and non-classical ISGs, which are spatially stimulated by IFNT within
the stroma/dGE and LE/sGE, respectively [42, 43]. Type I and II IFNs initiate the expression of
classical ISGs through stimulation Jak-STAT pathways resulting in phosphorylation of their
respective receptors activating STAT. Classical ISGs expressed in the stroma/dGE in response to
IFNT include STAT1 and STAT2, IRF1, ISG15, and 2’-5’-oligoadenylate synthetase 1 (OAS1)
[45, 156, 157]. Transcriptomic analysis of ruminant endometrium has led to the identification of
non-classical ISGs which are stimulated by IFNT and are primarily induced by P4 spatially in
the LE/sGE [20, 41]. Genes include CST3, CTSL, and LGALS15 in sheep [42]. In the LE/sGE,
interferon regulatory factor-2 (IRF2) prevents the IFNT from regulating gene expression of
classical ISGs.
Mathew et al. (2019) published data identifying conceptus and IFNT induced DEGs
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[143]. Endometrial explants were cocultured with d15 conceptuses from artificial insemination
or IVF origin, or 100 ng of IFNT, or media alone. Transcriptome differences were analyzed via
RNA-Seq and RT-qPCR. Conceptus induced, IFNT-dependant DEGs were identified through the
grouping of explant DEGs that were differentially expressed in response to all three treatment
groups as well as DEGs similar between the IFNT and AI conceptus treated explants [143].
Galectins are a large family of -galactoside-binding animal lectins that have numerous
physiological functions. Lectins bind carbohydrates and result in cell agglutination while playing
vital roles in pathogen defense, cell trafficking, and immune regulation [82, 83]. Galectins are
ancient members of a lectin family which are characterized by having conserved amino acid
sequences with at least one CRD and the ability to recognize -galactoside structures located on
cell surface glycoconjugates [85, 86]. Elongating bovine embryos have been found to express
galectin-1 (LGALS1) and LGALS3. Recently, LGALS3 was identified to play an important part in
the preparation of the endometrium for implantation with a presence in the endometrium and
trophoblast cells. Given the resemblances of tumor invasion and the migration of trophoblast
cells, investigators have addressed the possible roles of LGALS3 at the maternal-fetal interface
regarding implantation [115, 116]. After conducting IHC studies on pregnant murine
uteroplacental tissue samples, it was concluded that LGALS3 is synthesized by all cell types
within the murine uteroplacental samples. Levels of LGALS3 mRNA remained constant in
murine uterine tissues until d12 of gestation and declined thereafter until parturition.
Interestingly, in placental tissues, LGALS3 mRNA levels remained constant after d12 of
gestation until term [115]. In bovine tissues, LGALS3 protein has been identified in the cervix,
oviduct, uterus, atretic follicles, and CL [117]. Specifically, in the nonpregnant bovine uterus,
LGALS3 has been localized via IHC in epithelial cells as well as macrophages located in the
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submucosa but were absent in endometrial glands [117].
In the past, 2D monoculture techniques have been utilized to investigate cellular
processes of bovine epithelial and fibroblast cells [129, 130]. The 3D transwell culture system
published by MacKintosh et al. (2013) enables the coculture of two cells types, which would
normally interact in vivo [127]. MacKintosh et al. utilized bovine endometrial epithelial and
fibroblast cells in this system to investigate the effects of lipopolysaccharide (LPS) in a postpartum uterine disease [127]. To better simulate the columnar arrangement of epithelial cells in
vivo, a 3D culture allows epithelial cells to maintain a physiological polarity in vitro due to tight
junctions unlike traditional 2D cell culture techniques [127, 128]. Tight junctions are imperative
to epithelial cellular functions because the passage of ions and molecules paracellularly is
regulated by tight junctions. A measurement that reflects epithelial integrity, TEER, can be
measured via an epithelial volt-ohm meter [127].
This aim of this study was to examine the effect of IFNT and LGALS3 on bovine
endometrial epithelial and fibroblast cell transcriptomes when cells are cultured in a 3D
environment.
MATERIALS AND METHODS
Primary Cell Isolation, Culture, and Treatment
Bovine reproductive tracts utilized to isolate endometrial cells were collected from a local
abattoir. The tracts were chosen based on the appearance of a mid-luteal phase CL and the
absence of either pregnancy and/or infection [158]. Cells were isolated from different animals for
the IFNT Experiment (Experiment 1; n=3-4) and LGALS3 Experiment (Experiment 2; n=4-5).
The reproductive tracts were immediately placed on ice and transported to the laboratory. Upon
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arrival at the laboratory, reproductive tracts were rinsed with water, and the broad ligament and
the cervix were removed. The remaining reproductive tract was sprayed with 70% ethyl alcohol
(EtOH), and the uterine horn ipsilateral to the CL was removed with a scalpel. The tract was then
placed in a cold dissecting tray lined with 70% EtOH soaked paper towels and sprayed once
again with 70% EtOH. A cut was made along the anti-mesometrial side of the uterine horn
ipsilateral to the CL.
Bovine endometrial epithelial and fibroblast cells were isolated from uterine horn
ipsilateral to the CL [127]. Briefly, the exposed endometrium was rinsed with 1X phosphate
buffered saline (PBS) (Gibco, Gaithersburg, MD) containing 1% antibiotic-antimycotic (ABAM)
(Gibco). Thin intercaruncular endometrial strips were dissected and placed in 25 mL of hank’s
balanced salt solution (HBSS) (Gibco). Endometrial strips were washed twice in 25 mL of HBSS
and trimmed into 3-5 mm pieces and washed in a final HBSS wash (25 mL) containing 1%
ABAM. Endometrial strips were then incubated for 10 min at 38.8°C in atmospheric oxygen and
5% CO2. The wash was then drained from the conical tube and 40 mL of filter-sterilized enzyme
solution [49.5 mL HBSS, 25 mg Collagenase II (Sigma-Aldrich), 50 mg bovine serum albumin
(BSA) (Sima-Aldrich), 700 µL Trypsin-EDTA-HBSS solution (Sigma-Aldrich; Gibco), and 125
µL DNase I (Sigma-Aldrich)] was added. The endometrium in enzyme solution was placed in a
water bath at 38.8°C for 1 h with manual agitation every 10 min.
Following incubation, the endometrium in enzyme solution was filtered through a 100
M filter placed over a 40 M filter (Corning Inc.; Tewksbury, MA). The filtered solution was
placed with 5 mL of prewarmed (38.8°C) HBSS with 10% fetal bovine serum (FBS) (VWR
International, Radnor, PA). The 40 M filter, containing sheets of epithelial cells, was then
overturned and washed with 30 mL of pre-warmed (38.8°C) Roswell Park Memorial Institute
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1640 (RMPI) (Gibco), 5% FBS (VWR International), and 1% ABAM (Gibco) (complete media).
Fifteen mL aliquots of the cell suspension were transferred into T75 flasks (Greiner Bio-One,
Monroe, NC) and cells were allowed to attach for 48 h at 38.8°C in atmospheric oxygen and 5%
CO2. Fibroblasts, in filtered solution, were centrifuged at 700 x g for 7 min at 25°C. The
supernatant was aspirated and 5 mL of prewarmed (38.8°C) sterile water was added to the pellet
and lightly vortexed for 30 s. After, 45 mL of HBSS (Gibco) containing 10% FBS (VWR
International) was added to the cells which were then filtered once again through a 40 M filter.
Flow through was centrifuged at 700 x g for 7 min at 25°C. The supernatant was aspirated and
45 mL of complete media was added to re-suspend pellet. Fifteen mL aliquots were added to T75
flasks which were placed in the incubator at 38.8°C in atmospheric oxygen and 5% CO2. After
18 h, fibroblasts in flasks were washed with 10 mL of prewarmed 1X PBS (Gibco) and 15 mL of
complete media was added. Every 2d, both fibroblast, and epithelial flasks were rinsed with 1X
PBS (Gibco) and 15 mL of fresh complete media was added until the cells reached confluency.
Once approximately 80% confluent, cells were dislodged from the flask with 1.5-2 mL of
Accutase (Sigma-Aldrich) and passed into new T75 flasks in complete media.
Cells were counted using a hemocytometer and once the epithelial cell concentration of
3x105 cells/mL was reached, cells were removed using 2-3 mL of Accutase (Sigma-Aldrich) and
placed in polyethylene terephthalate transwell cell culture inserts with a pore size of 0.4 µm
(Millipore Sigma, Burlington, MA). Before the addition of epithelial cells, transwell inserts were
coated with 25-30 µL of Matrigel (Corning Inc.) with ice-cold RPMI (Gibco) at a 1:8 dilution.
Transwell inserts were placed in a 24-well plate containing 800 L of complete media. Cells
were cultured in transwell inserts for 9d. On d9 (day of treatment), TEER was calculated using
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the following formula: TEER (Ωcm2) = (sample resistance – blank resistance) X membrane area.
Resistance values were obtained by using a Millicell ERS-Voltohmmeter (Millipore Sigma).
The 3D cultures were conducted as previously described [127]. The day prior to treatment, 1 mL
of fibroblast cells at the concentration of 1 X 105 cells/mL were plated per well in new 24 plates.
Fibroblasts were allowed to adhere and 18 h later, the cells were washed with 1 X PBS (Gibco)
and new media was added [treatment media; RPMI (Gibco), 5% FBS (VWR International), and
1% ABAM (Gibco)]. The transwell inserts containing epithelial cells were then added to the
fibroblast cells and new treatment media was added to the transwell inserts.

Experiment One
After 2 h, new treatment media alone (Control) or treatment media containing 100 ng of
recombinant ovine IFNT (oIFNT), kindly donated by Dr. Gilles Charpigny of INRA, Biologie du
Développement et Reproduction (Jouy en Josas, France), was added to well inserts containing
epithelial cells for 6 h [143]. Fibroblast cell media was not changed. The experiment was
repeated at least 4 times (cells from 4 different uteri). However, the oIFNT treatment for one
uterus was lost, therefore, n=3-4. Both treatments were applied to three 3D cell cultures from
each uterus.

Experiment Two
After 2 h, 300 µL of new treatment media alone (Control), d14 pregnant ovine flush fluid
(FF) (diluted 1:1 with treatment media), or treatment media containing either 100 or 1000 ng of
recombinant mouse LGALS3 protein (Catalog Number: 9039-GA; R&D Systems, Minneapolis,
MN) was added to well inserts containing epithelial cells for 6 h. The ovine pregnant uterine
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flush fluid, theoretically containing IFNT, was obtained during a previous study by flushing the
uterine horn ipsilateral to the CL of a d14 pregnant ewe with 20 mL of 1 X PBS (Thermo
Fisher). The presence of a conceptus confirmed pregnancy. Fibroblast media was not changed.
The experiment was replicated with cells from five different uteri. The FF treatment from one
replication was lost, therefore, n=4-5 uteri. All treatments were applied to three 3D cell cultures
from each uterus.

RNA Isolation and RNA Sequencing (RNA-Seq)
Total RNA was extracted from both cell types, separately, using the Qiagen RNeasy Kit
(Qiagen) for Experiment one while the E.Z.N.A. Total RNA Kit I (Omega Bio Tek, Inc.) was
used to collect RNA for Experiment two. Both kits were used according to the manufacturer’s
recommendations. Briefly, the media was collected and the membrane from transwell inserts was
removed using a scalpel, placed in lysis buffer, and agitated using a pipette tip. Lysis buffer was
added to fibroblast cells in wells and gently scraped using a pipette tip to obtain fibroblast RNA.
The three RNA samples per treatment for both cells types were pooled. The concentration of
RNA and integrity was determined using NanoDrop (NanoDrop ND-1000, NanoDrop
Technologies) and Bioanalyzer (2100 Bioanalyzer, Agilent Technologies), respectively. The
RNA integrity number (RIN) values obtained from the Bioanalyzer ranged from 8.6-10.0. The
RNA was stored at -80°C until cDNA was synthesized.
RNA library preparation and sequencing was performed by the University of Missouri
DNA Core facility as previously described by Moraes et al. [159]. The raw sequences (fastq)
underwent adapter removal and quality trimming utilizing Trimmomatic [160]. The quality reads
were then mapped to the bovine reference genome ARS-UCD1.2 using Hisat2 mapper, a
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sensitive and fast alignment program of next-generation sequencing data [161]. The sorted
binary alignment maps and the NCBI gene annotation of the ARS-UCD1.2 assembly were
subjected to FeatureCounts [162] to quantify read counts of genes for each sample. Differential
gene expression analysis between sample groups was performed by robustly fitting the
expression data to a weighted generalized linear model (GLM) using edgeR robust [163].
To perform a Gene Ontology (GO) analysis of statistically significant transcripts
generated by RNA-Seq data, DAVID Bioinformatics Resource 6.8 was utilized [164]. Pathway
analyses included were an enriched biological process (BP) in addition to the Kyoto
Encyclopedia of Genes and Genomes (KEGG). During the annotation, the GO Direct category
was used which provides mappings directly annotated by the source database and the Homo
sapien background was used during the analysis. The GO Direct and KEGG categories were
considered enriched when P ≤ 0.05.

Reverse Transcription and Quantitative real-time PCR (RT-qPCR)
Following the manufactures recommendations, cDNA was synthesized using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Briefly, 500 ng of RNA and
nuclease-free water was added to 10 µL of master mix to reach a total volume of 20 µL. Noreverse transcriptase control samples were also prepared. Following a 2 h cDNA synthesis at
37˚C, 5 µL of each sample was pooled and the remaining cDNA was diluted 1:20 using
nuclease-free water. Pooled cDNA was used to generate 7 standards (1:4 serial dilutions).
Standards were used to calculate primer efficiencies (E) using the following equation: E = [10(1/slope)-1].

The slope is a plot of observed Ct values versus the 7 standard serial dilutions. Percent

efficiency was then obtained by dividing E by 2 and multiplying by 100.
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Quantitative real-time PCR was utilized to examine gene expression differences in
response to treatment and to verify the data obtained from RNA-Seq. The CFX96 Real-Time
PCR machine (Bio-Rad Laboratories) was used to perform RT-qPCR reactions. All primers were
designed using Primer3Plus (Version 2.4.2) unless otherwise noted. Sample RT-qPCR reactions
were carried out in 20 L reactions in duplicate [10 L of SYBR Green Master Mix (Catalog
Number: A25743; Applied Biosystems), 1.2 L of forward and reverse primer mix (1 µM final
concentration), 2.6 L nuclease-free water, and 5L of cDNA template (6.6 ng RNA
equivalent)]. The RT-qPCR reaction of no-reverse transcriptase controls and no-template
controls were included. All samples from an experiment were assayed in a single 96-well plate.
Thermo-cycling conditions were as follows: 50°C for 2 min, 95°C for 2 min, which was
followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. A disassociation analysis was
included for each primer set and the presence of a single, sharp peak was confirmed.
The qbase+ package (Biogazelle) was used to analyze and calculate relative gene
expression values. Average RT-qPCR Ct values were imported into qbase+ software, which was
used to analyze real-time data and generate the normalized relative quantity (NRQ) of genes of
interest using a generalized delta-delta quantification cycle method (ΔΔCq; also known as
ΔΔCT)[141]. A panel of eight prospective reference genes was analyzed (GAPDH, ACTB,
RPL18, PPIA, YWHAZ, RNF11, H3F3A, SDHA) across a subset of 12 random cDNA samples
and two reference genes were selected using the qbase+ geNorm function [141]. Expression was
normalized to two housekeeping genes, succinate dehydrogenase complex flavoprotein subunit
A (SDHA) and ring finger protein 11 (RNF11) in the oIFNT Experiment and the two genes,
peptidylprolyl isomerase A (PPIA) and SDHA, in the LGALS3 Experiment. These reference
genes were found to be the most stably expressed across the subset of samples for each
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experiment (geNorm M ≤ 0.5) [142]. Sizes of RT-qPCR amplicons were validated using gel
electrophoresis (0.8% agarose gel, 1X Tris/Borate/EDTA Buffer, and 0.5 µg/mL ethidium
bromide) and a 50 bp DNA ladder (New England BioLabs). Gels were visualized under ultraviolet (UV) light using the DigiDoc-It Imaging System (Analytik Jena).

Statistical Analysis
Log-transformed sample NRQ data were analyzed using the proc GLM in the statistical
analysis software (SAS Institute Inc.). The analysis tested the effect of recombinant oIFNT
(Experiment one) or recombinant mouse LGALS3 (Experiment two) on endometrial cell gene
expression. The epithelial and fibroblast NRQ data were analyzed separately. Residual data were
scrutinized for normality using the PLOTS= (diagnostics residuals) statement. If residuals were
not normally distributed, they were square root (sqrt) transformed. Data are presented as nontransformed least square means ± standard error of the least squares means (LSM ± SEM).
Statistical significance was declared at P ≤ 0.05.

RESULTS
Experiment One
Differentially Expressed Genes in Response to oIFNT
The RNA-Seq analysis identified 673 and 83 DEGs (up- or down-regulated) in the
epithelial and fibroblast cells, respectively, in response to treatment with 100 ng of oIFNT in the
3D culture system (P ≤ 0.001; FDR P ≤ 0.05; Figure 3.2). Epithelial cell data consisted of 632
and 41 DEGs that were up- and down-regulated, respectively. Fibroblast cell data identified 83
DEGs that were up-regulated and 0 DEGs that were down-regulated. To potentially identify
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conceptus IFNT responsive genes specifically in epithelial and fibroblast cells, data were
compared to recently published RNA-Seq data of bovine endometrial explants incubated with an
elongating, d15 bovine conceptus and explants treated with 100 ng/mL of recombinant oIFNT.
The DEGs, published by Mathew et al. (2019) were considered to be conceptus induced, IFNT
dependent DEGs (Figure 3.2) [143]. Comparison of DEGs between epithelial cells and fibroblast
cells treated with 100 ng/mL of oIFNT in a 3D environment with the conceptus induced, IFNT
dependent DEGs resulted in the identification of 224 DEGs in common with explants and
epithelial cells or fibroblast cells in 3D culture (Figure 3.2). Sixty-nine DEGs were in common
between all three groups (Figure 3.2). Explants shared 154 DEGs with epithelial cells only and a
single gene was differentially expressed in explants and fibroblast cells only (Figure 3.2). All
DEGs in common between explants (Mathew et al. 2019) and endometrial cells in 3D culture
from the current study were up-regulated [143].

Epithelial-Derived DEGs in Response to oIFNT
Analysis of RNA-Seq data resulted in the identification of 632 genes that were upregulated and 41 genes that were down-regulated in bovine endometrial epithelial cells in
response to treatment with 100 ng/mL of oIFNT (P ≤ 0.001; FDR P ≤ 0.05; Figure 3.2).
Epithelial cells shared 223 up-regulated genes with explant data and 154 of these DEGs were upregulated only in the epithelial cells during 3D culture. The top 10 genes with the greatest log
fold change (logFC) of the 223 DEGs shared between explants and epithelial cells were kinesin
family member 5C (KIF5C; logFC 8.66), hematopoietic SH2 domain containing (HSH2D; logFC
7.86), ATPase phospholipid transporting 8B4 (ATP8B4; logFC 7.52), indoleamine 2,3dioxygenase (IDO1; logFC 7.18), forkhead box S1 (FOXS1; logFC 7.17), growth hormone
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secretagogue receptor (GHSR; logFC 5.67), prostate androgen-regulated mucin-like protein 1
(PARM1; logFC), apolipoprotein L3 (APOL3; logFC 5.34), melanin concentrating hormone
receptor 1 (MCHR1; logFC 4.88), and guanylate-binding protein 2 (GBP2; logFC 4.52) (Figure
3.2; Table 3.2).The top 20 DEGs in common out of the 223 DEGs are listed in Table 3.2 with
their respective epithelial log fold change differences and fibroblast log fold change differences,
if applicable. Of the 223 DEGs, 69 were also up-regulated in both epithelial and fibroblast cells
in response to oIFNT (Figure 3.2).
Further analysis of DEGs shared between explants and epitheial cells through RT-qPCR
validated that genes including MX dynamin like GTPase 1 (MX1) (Figure 3.3; 1.92  15.45 and
59.62  17.83; Control and oIFNT, respectively; LSM  SEM; P < 0.05), MX2 (Figure 3.4; 0.59
 37.32 and 680.18  43.1; Control and oIFNT, respectively; LSM  SEM; P < 0.001), OAS1
(Figure 3.5; 0.80  10.34 and 39.03  11.94; Control and oIFNT, respectively; LSM  SEM; P
< 0.05;), galectin-3 binding protein (LGALS3BP; Figure 3.6; 0.72  0.40 and 2.79  0.50;
Control and oIFNT, respectively; LSM  SEM; P < 0.001), galectin-9 (LGALS9; Figure 3.7;
3.07  2.99 and 36.78  3.45; Control and oIFNT, respectively; LSM  SEM; P < 0.001), OAS2
(Figure 3.8; 0.59  1.06 and 9.97  1.22; Control and oIFNT, respectively; LSM  SEM; P <
0.01;), BATF2 (Figure 3.9; 0.59  1.03 and 8.51  1.19; Control and oIFNT, respectively; LSM
 SEM; P < 0.001), and TNF superfamily member 13b (TNFSF13B; Figure 3.12; 0.48  0.80
and 12.7  0.93; Control and oIFNT, respectively; LSM  SEM; P < 0.001) were significantly
upregulated in the oIFNT treated epithelial cells. Microtubule associated protein 6 (MAP6) was
found to be significantly down-regulated after oIFNT treatment by RNA-Seq (logFC -6.50; P ≤
0.001; FDR P ≤ 0.05) and RT-qPCR validation of this gene exhibited MAP6 expression in
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response to IFNT was less than in control cells, although not significantly (Figure 3.11; 1.86 
0.30 and 0.35  0.35; Control and oIFNT, respectively; LSM  SEM; P = 0.17).

Fibroblast-Derived DEGs in Response to oIFNT
The RNA-Seq data identified 83 up-regulated and 0 down-regulated transcripts in
fibroblast cells treated with oIFNT in the 3D cell culture (P ≤ 0.001; FDR P ≤ 0.05). Fibroblast
cells shared 69 DEGs with both explants and epithelial cells, all of which were up-regulated. Of
the 69 genes, the following were the top 10 greatest up-regulated in fibroblast cells: OAS2
(logFC 9.63), interferon induced protein 44 like (IFI44L; logFC 8.66), RSAD2 (logFC 8.35),
ZBP1 (logFC 8.06), MX2 (logFC 7.83), MX1 (logFC 7.77), PLAC8 (logFC 7.75), IFI44 (logFC
7.63), TNF superfamily member 10 (TNFSF10; logFC 7.50), and sterile alpha motif domain
containing 9 (SAMD9; logFC 7.46). A single transcript (also recently reported as a conceptus and
oIFNT induced DEG in endometrial explants), zinc finger CCCH-type antiviral protein 1
(ZC3HAV1; logFC 0.87) was differentially expressed in fibroblast cells (up-regulated) but not
epithelial cells (P ≤ 0.05) [143].
Validation of RNA-Seq data through RT-qPCR confirmed genes including MX1 (Figure
3.3; 0.01  0.14 and 5.28  0.17 Control and oIFNT, respectively; LSM  SEM; P < 0.001),
MX2 (Figure 3.4; 0.01  1.61 and 4.37  1.85 ; Control and oIFNT, respectively; LSM  SEM;
P < 0.01), OAS1 (Figure 3.5; 0.04  0.95 and 10.86  1.09; Control and oIFNT, respectively;
LSM  SEM; P < 0.001), LGALS3BP (Figure 3.6; 0.58  0.07 and 1.18  0.08; Control and
oIFNT, respectively; LSM  SEM; P < 0.01), LGALS9 (Figure 3.7; 0.04  0.15 and 0.79  0.18;
Control and oIFNT, respectively; LSM  SEM; P < 0.05), OAS2 (Figure 3.8; 0.25  0.13 and
1.62  0.15; Control and oIFNT, respectively; LSM  SEM; P < 0.001), BATF2 (Figure 3.9;
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0.30  0.25 and 1.55  0.29; Control and oIFNT, respectively; LSM  SEM; P < 0.01), and
TNFSF13B (Figure 3.12; 0.33  0.35 and 1.48  0.41; Control and oIFNT, respectively; LSM 
SEM; P < 0.05) were increased in response to oIFNT treatment. Expression of ZC3HAV1 in
epithelial cells was unaltered by the presence of oIFNT protein in culture, while in fibroblast
cells, expression of this gene increased due to oIFNT (Figure 3.13; Control and oIFNT,
respectively; LSM  SEM; P < 0.05).

Gene Ontology Analysis
The gene ontology analysis of the 223 up-regulated epithelial DEGs in response to
oIFNT identified 97 enriched biological processes (P ≤ 0.001; Table 3.4). The top 5 enriched
pathways include the following: 1) type I interferon signaling pathway, 2) defense response to
virus, 3) interferon-gamma mediated signaling pathway, 4) response to virus, and 5) negative
regulation of viral genome replication (P ≤ 0.001; Table 3.4). The KEGG pathway analysis
found 12 enriched pathways (P ≤ 0.05; Table 3.4). The top 5 pathways include 1) influenza A, 2)
herpes simplex infection, 3) hepatitis C, 4) measles, 5) RIG-1-like receptor signaling pathway (P
≤ 0.001; Table 3.4).
The 70 oIFNT-stimulated DEGs in fibroblast cells, which includes the 69 shared with the
epithelial cells and ZC3HAV1, were identified to be associated with 43 biological processes. The
top 5 enriched pathways include 1) defense response to virus, 2) type I interferon signaling, 3)
response to virus, 4) negative regulation of viral genome replication, and 5) interferon-gammamediated signaling pathway (P < 0.001; Table 3.5). The KEGG pathway analysis found 7
enriched pathways (P ≤ 0.05; Table 3.5). The top 5 pathways include 1) influenza A, 2) herpes
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simplex infection, 3) measles, 4) RIG-I-like receptor signaling, and 5) hepatitis C (P ≤ 0.001;
Table 3.5).

Experiment Two
The Effect of Mouse-LGALS3 on Bovine Endometrial Epithelial and Fibroblast Cells in 3D
Culture
The effect of a recombinant mouse LGALS3 protein on bovine endometrial epithelial and
fibroblast cells in 3D culture was analyzed by RNA-Seq. Results indicated a single gene, 60S
ribosomal protein L23A (RPL23A), was up-regulated in epithelial cells (log FC 4.05). The
transcriptome of fibroblast cells was not affected by LGALS3 treatment. The gene, RPL23A, was
analyzed through RT-qPCR, however, an increase in expression of this gene was unable to be
validated using this method (Table 3.6). The cells that received the lower concentration of
LGALS3 protein (100 ng) and the control-treated cells were analyzed through RNA-Seq. The
relative expression of other genes including C-X-C motif chemokine receptor 4 (CXCR4),
doublesex- and mab-3-related transcription factor A1 (DMRTA1), ISG15, LGALS3BP, leukemia
inhibitory factor (LIF), proline-rich transmembrane protein 3 (PRRT3), and scavenger receptor
cysteine-rich family member with 4 domains (SSC4D) was assessed through RT-qPCR to see
whether a higher concentration of LGALS3 (1000 ng) affected their expression. Of the genes
analyzed, neither concentration of LGALS3 affected their relative expression (Table 3.6).
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The Effect of Day 14 Pregnant Ovine Flush Fluid on Endometrial Epithelial and Fibroblast Cell
Transcriptomes Cultured in 3D
The ovine flush fluid treatment up-regulated expression of CXCR4 (5.12 ± 0.98 and 9.50
± 1.10; Control and FF, respectively; LSM  SEM; P < 0.01), ISG15 (0.50 ± 5.31 and 130.27 ±
5.94; Control and FF, respectively; LSM  SEM; P < 0.001), LGALS3BP (0.98 ± 0.16 and 4.12
± 0.18; Control and FF, respectively; LSM  SEM; P < 0.001), and LIF (4.27 ± 0.77 and 7.11 ±
0.86; Control and FF, respectively; LSM  SEM; P < 0.05) as indicated by RT-qPCR (Table
3.6).

DISCUSSION

The aim of this study was to identify IFNT and LGALS3 induced DEGs in the bovine
endometrial epithelium and fibroblast cells in a 3D cell culture system. To date, several studies
have addressed endometrial genes stimulated by the elongating ruminant conceptus particularly
in sheep, however, literature is lacking information examining differential expression within
endometrial epithelial and/or stromal cells, specifically, during early bovine pregnancy [143,
165, 166].
Endometrial cells of the uterus regulate maternal-conceptus communication through the
differential expression of genes. The endometrium also contains other cells including glands,
endothelial cells, and immune cells. Past research has noted that endometrial epithelial and
fibroblast cells, which largely comprise the endometrium, have different expression profiles [38,
167-169]. During this preimplantation and conceptus elongation in ruminants, genes
differentially expressed in fibroblasts have been documented to be associated with maternal
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immunosuppression to protect the semi-allogenic conceptus [42, 165]. The JAK-STAT
signaling pathway is activated via IFNT to stimulate classical ISGs during the elongation phase
in the ruminant endometrium [170]. Epithelial and fibroblast cells treated with IFNT in the 3D
cell culture had 69 differentially expressed transcripts in common with bovine endometrial
explants treated with IFNT or an elongating Day 15 conceptus. There were 154 DEGs shared
specifically between the epithelial cells and explants that were not shared with the fibroblasts.
On the other hand, there was one DEG shared between the fibroblast cells and explants but not
with the epithelial cells [143].

3D Cell Culture
Epithelial and fibroblast cell-specific responses to IFNT have not been elucidated,
particularly in a 3D cell culture system. Recently, 3D cell culture models have been utilized to
investigate cellular communication mechanisms and responses. Mackintosh et al. (2013) found
the coculture of bovine endometrial epithelial and stromal cells enabled the polarization of
epithelial cells. The 3D cultures were treated with oxytocin and arachidonic acid to assay the
physiological function of the model. The cells were also treated with lipopolysaccharide (LPS) to
mimic a bacterial infection. In the present study, we assessed the use of a 3D culture system to
study maternal-conceptus crosstalk.
The IFNT was administered apically to the 3D culture. The RNA-Seq data identified 673
DEGs in epithelial cells and 83 DEGs in fibroblast cells (P ≤ 0.001; FDR P ≤ 0.05), therefore,
apical treatment to the 3D system elicited a response in both cell types. We do not know if the
IFNT traveled through the epithelium layer to modify the fibroblast cell transcriptome or it the
epithelial cells secreted factors basolaterally in response to IFNT to modify fibroblast cell gene
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expression. Considering conceptus IFNT can leave the endometrium and travel systemically, it is
possible that IFNT traveled either paracellularly or transcellular to reach the fibroblast cells [171,
172].

Classical and Non-Classical ISGs stimulated by IFNT
Endometrial transcriptomic reported by Forde et al. (2011) of d16 cyclic and pregnant
heifers consisted largely of classical ISGs including B2M, interferon alpha-inducible protein 6
(IFI6), ISG15, MX2, MX1, OAS1, and STAT1 [168]. The bovine endometrium has also been
found to respond earlier than d16 as d8 blastocysts and d15 conceptuses have been documented
to alter endometrial gene expression in bovine endometrial explants cultured with explants [143,
153]. The 3D cultured bovine endometrial epithelial and fibroblast cells exhibited a significant
upregulation of classical ISGs including IFIT1, ISG15, MX2, OAS2, and RSAD2 in response to
IFNT treatment (Table 3.3). These genes were also recently reported to be up-regulated genes in
explants treated with IFNT or a conceptus [143]. The gene, RSAD2, is believed to be involved in
the development of an antiviral endometrial environment via the inhibition of an innate immune
response [173, 174].
The role of various classical ISGs is still undetermined. The endometrial up-regulation of
the classical ISG, ISG15, is associated with infection prevention and is hypothesized to protect
the developing conceptus from a negative inflammatory response [175]. In sheep, ISG15, IFIT1,
and RSAD2 have been identified to be up-regulated by IFNT in the endometrial glandular
epithelium and fibroblast cells after d14 of gestation [41, 42]. This agrees with data from the
current study as these genes were found to be up-regulated by IFNT in both epithelial and
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fibroblast cells as well as by the coculture of endometrial explants with an elongating conceptus
and IFNT.
Factors, including IFNT and P4, stimulate ovine endometrial genes in a cell-specific
manner. Expression of IFNT and P4 responsive genes, including the non-classical ISGs,
LGALS15, and CTSL, were shown to be upregulated in the epithelium by d14/15 of both
pregnant and cyclic sheep, however, expression then resided by d16 in cyclic sheep. This led to
the conclusion that LGALS15 and CTSL are stimulated by P4, IFNT extends their expression
[167, 176]. Bovine and ovine IFNT responsive endometrial genes vary as LGALS15, a gene
highly upregulated during early pregnancy in sheep is not present in cattle [177]. Non-classical
ISGs are hypothesized to influence proliferation, migration, attachment, and adhesion of the
trophectoderm to support elongation of the conceptus [169]. The gene, LGALS3BP, has been
previously reported to be abundant in both pregnant and cyclic d16 uterine luminal fluid and
endometrium of heifers in comparison to d13 [138, 168, 178]. Galectin-9 was upregulated in
epithelial and fibroblast cells in response to IFNT treatment, while LGALS3BP was found to only
be up-regulated in epithelial cells (Table 3.2). Both LGALS3BP and LGALS9 are also reported as
being stimulated by a conceptus and IFNT in bovine endometrial explants [143]. During
implantation, LGALS9 has been suggested to play an immunomodulatory role through the
regulation of endometrial leukocytes in humans [151]. The recently classified non-classical ISG,
LGALS9 has been suggested to play an immunomodulatory role through the regulation of
endometrial leukocytes during human implantation [151]. Through interaction with LGALS3,
LGALS3BP forms cell aggregates and is involved in cell adhesion [179].
In the ovine model, IRF2 acts to suppress the transcriptional effects of IFNT on luminal
epithelial cells, thereby inhibiting the up-regulation of many endometrial classical ISGs [45].
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Classical ISGs contain at least a single IFN-stimulated response element (ISRE) in their
promoter of which IRF2 acts to inhibit transcriptional activity [169]. Induced by IFNT, IRF1 is
hypothesized to increased classical ISG expression in the stroma. Both IRF1 and IRF2 were upregulated in the epithelial cells in response to IFNT (logFC 0.76 and 0.66, respectively; Table
3.2).
Members of the family of proteins known as SLC transporters are important during
conceptus elongation in ruminants as they transport endometrial amino acids into the uterine
lumen for nourishment [25, 26]. It is believed that the effects of IFNT and P4 trigger an increase
in amino acids to be transported to the uterine lumen [180]. Solute carrier family 14 member 3
(SLC15A3) is an amino acid transporter that transports lysosome histidine and peptides and was
found to be elevated in bovine gestational d18 endometrial tissue [165]. Groebner et al. (2011)
found mRNA expression of SLC15A3 increased in response to recombinant bovine IFNT
treatment to cocultured bovine glandular epithelial and stromal cell. The stromal cells exhibited a
significant 177-fold increase of SLC15A3 while glandular epithelial cells had a 36-fold increase
[181]. Data from the current study show the up-regulation of SLC15A3 in the epithelial and
fibroblast cells due to IFNT (logFC 6.29 and 7.06, respectively; Table 3.2). Previously, SLC15A3
was identified to be IFNT-dependent along with other SLC transporters including the
mitochondrial transporter of an unknown solute, solute carrier family 25 member 30
(SLC25A30), and the mitochondrial thiamine pyrophosphate transporters, solute carrier family 25
member 28 (SLC25A28) and solute carrier family 25 member 19 (SLC25A19) [143]. The
transporters SLC25A30, SLC25A28, and SLC25A19 were all up-regulated by IFNT in 3D
cultured epithelial cells in the current study (logFC 1.34, 2.54, and 1.27, respectively; Table 3.2).
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Despite the apical IFNT treatment to the 3D culture of bovine endometrial epithelial and
fibroblast cells, IFNT affected fibroblast gene expression as exhibited by the up-regulation of the
gene ZC3HAV1 in the fibroblast cells alone. The gene, ZC3HAV1, is an ortholog of zinc-finger
antiviral protein (ZAP) which degrades viral RNA through direct binding [182]. Zinc finger
CCCH-type antiviral protein 1 has antiviral properties as the CCCH zinc-finger motif binds viral
RNA directly [183, 184]. Ozawa et al. (2012) identified ZC3HAV1 as a gene that is up-regulated
in the inner cell mass of d8 in vitro produced blastocysts in comparison to the trophectoderm
[185]. The role of IFNT induced ZC3HAV1 within bovine endometrial stromal cell is unknown.
Forde et al. (2015) found LGALS3 mRNA was expressed by both the d16 endometrium
and conceptus but was more abundant in the d16 conceptus [178]. Therefore, we attempted to
test the function of LGALS3 in the bovine endometrium using a 3D cell culture system. Bovine
endometrial epithelial and fibroblast cells in the 3D culture were treated with 100 and 1000 ng of
recombinant mouse LGALS3 protein. Compared to Control epithelial cells, epithelial cells
treated with LGALS3 had greater expression of a single gene, RPL23A (logFC 4.05). However,
RPL23A gene expression differences were unable to be detected when assayed by using RTqPCR (Table 3.6). Six pseudogenes for RPL23A are present in the bovine genome, therefore, it is
possible we did not amplify the correct transcript by RT-qPCR. The cells that received the lower
concentration of LGALS3 (100 ng) were analyzed by RNA Seq, we investigated the gene
expression all samples to examine if the higher dose of LGALS3 (1000 ng) resulted in
significant gene expression differences. Of the genes examined, we were unable to detect
differences between either LGALS3 treatment (100 and 1000 ng) and the Control-treated
epithelial and fibroblast cells. A previous study successfully utilized recombinant LGALS3
protein from humans and an unidentified mammal in vitro to elicit a response on cultured bovine
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luteal cells [118]. However, we conclude that recombinant mouse LGALS3 protein did not elicit
a cellular response in the bovine cells. Further studies utilizing recombinant bovine LGALS3
may conclude a role for LGLAS3 during early pregnancy during cattle. Recombinant bovine
LGALS3 was not available to test the responsiveness of the endometrium cells in experiment
two, therefore, we treated the cells with uterine FF collected from d14 pregnant sheep.
Theoretically, the ovine FF contained IFNT produced by the conceptus. The endometrial cells
treated with the ovine FF did increase the expression of IFNT stimulated genes (ISG15 and
LGALS3BP; Table 3.6) indicating the cells were responsive. Interestingly, CXCR4 and LIF,
genes are known to be important for implantation in mammals were also increased in the
endometrial cells in response to pregnant ovine uterine FF (Table 3.6). The role LGALS3 plays in
the endometrium and early ruminant embryo requires further investigation.

CONCLUSIONS

Findings from this study support the utilization of 3D culture of bovine endometrial cells
to study early conceptus-maternal crosstalk and identify endometrial cell type-specific responses
to the conceptus. We identified 154 IFNT-responsive genes specifically in the endometrial
epithelial cells that were previously found to be upregulated in total endometrium treated with
IFNT and d15 elongating bovine conceptuses [143]. A single gene, ZC3HAV1, also found to be
upregulated in total bovine endometrium treated with IFNT and d15 bovine conceptuses, was
upregulated in the fibroblast but not the epithelial cells. Sixty-nine genes were differentially
expressed in both epithelial and fibroblast cells. Expression of specific IFNT responsive genes
within specific tissue compartments of the endometrium may have important functions during
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maternal recognition of pregnancy and placentation in ruminants. The role of IFNT responsive
genes and uncharacterized conceptus secretory proteins, such as galectins, needs further
investigation.
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Table 3.1. GenBank accession number, gene name, primer direction, primer sequence, product
size, percent amplification efficiency, and source of primer of cDNAs amplified during
real-time quantitative polymerase chain reaction (RT-qPCR).
GenBank
Acc. Number

Gene

Primer

Primer Sequence (5’-3’)

NM_178320

PPIA

NM_174178

SDHA

NM_001040516.1

RPL19

NM_174814.2

YWHAZ

NM_001077953.1

RNF11

NM_001034034.2

GAPDH

NM_173979.3

ACTB

NM_001014389.2

H3F3A

NM_001029846.1

OAS1

XM_010801645.3

MX1

NM_001077900.1

STAT1

NM_173941.2

MX2

NM_001015570.3

LGALS9

NM_001046316.2

LGALS3BP

NM_174301.3

CXCR4

NM_174366.1

ISG15

NM_001024557.1

OAS2

NM_001101866.2

IDO1

NM_001114506.1

TNFSF13B

XM_005216258.4

MAP6

NM_001192561.2

BATF2

XM_003586006.5

ZC3HAV1

XM_003587616.5

PRRT3

NM_001192640.1

DMRTA1

NM_001045958.2

RPL23A

XM_015475541.2

LIF

Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

CATACAGGTCCTGGCATCTTGTCC
CACGTGCTTGCCATCCAACC
ACTTCACCGTTGATGGCAA
GCAGAAATCGCATCTGAAA
GAAAGGCAGGCATATGGGTA
TCATCCTCCTCATCCAGGTT
ACCTACTCCGGACACAGAACATC
CCAGTTTGGCCTTCTGTACCA
TCCGGGAGTGTGTGATCTGTATGAT
GCAGGAGGGGCACGTGAAGG
TTCTACTGGCGCTGCCAAGG
GATCCACAACAGACACGTTGGG
CAGCAGATGTGGATCAGCAAGC
AACGCAGCTAACAGTCCGCC
CATGGCTCGTACAAAGCAGA
ACCAGGCCTGTAACGATGAG
CCCGGCGGACCCTACAGGAA
TCCAGCCAGACCAAAGCCGC
CGAGCCGAGTTCTCCAAATG
CAACTCTCTGCCACGATACC
GCATTAGTCAGGGCCCAAATTGTTACAG
GCCAGATACAGGAAGCTTTGCAC
GGGCAGCGGAATCATCACCCG
AGCTGCTGCGTAATGTTGCGGTA
TCAGCTTCCAGCCTCCAGGG
TCCAGGGGCGCTGTGTATGGT
CAACTGCAGACACGACAAGG
AGGGATTTCGCCAGATAGGT
AAGGCTCAGAAGCGCAAG
GAGTCGATGCTGATCCCAAT
CCAACCAGTGTCTGCAGAGA
CCCTAGCATCTTCACCGTCA
TGGATAACACCTGCTGGCTG
GGTCCAGGTGACTCGTTCTG
CACCCCAAAGAAGTTTGCCG
GCTGAATGCCCAGGAGAACA
GGGACGAACTGAGTCTGGTG
TCTTAGCATCTTCCCGGGGT
ATAAGCCAACCCCAGCTGAC
GGAGGTTCCTTGAAGGGCTC
ATCTCCTGCACAGCTGTCAC
AGGAACTCTAGAGGGGCAGG
AGGCCTTTTGTGACCCCAAA
TGTGACGGATGAAGGTGTGG
GAGGCCTGGGAAGTCAGTTC
GATGGGAGATCTGACGGCTG
CACGGCATTAACTTAGCGCC
TGACACAATTCCCGCGATGA
ATGAAGATGGCGCCGAAG
TGGCTGTGGACACCTTTCAA
GGGACAACTCAACAGCAGTG
GCACAGCTTGTCCAGGTTG
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Figure 3.1. The 3D cell culture system used to coculture bovine endometrial epithelial and
fibroblast cells. Epithelial cells were seeded on a transwell insert coated with Matrigel
(Corning Inc.) and fibroblast cells were located below inserts. The oIFNT or LGALS3
was administered apically.

IFNT

or LGALS3
Epithelium
Fibroblasts
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Figure 3.2. A Venn diagram (Venny 2.1 BioinfoGP) categorizing differentially expressed genes
(DEGs) in response to oIFNT among bovine endometrial intercaruncular explants and
bovine endometrial epithelial fibroblast cells cultured in a 3D system. Explants, treated
with oIFNT and d15 bovine conceptus [143], shared 224 transcripts with endometrial
epithelial and fibroblast cells. Of those DEGs, 154 were specific to the epithelium while a
single transcript, ZC3HAV1, was exclusive to the fibroblast cells cultured in the 3D
system. Explants treated with a conceptus or oIFNT shared 69 transcripts that were
differentially expressed with both epithelial and fibroblast cells treated with oIFNT.
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Table 3.2. Genes up- or down-regulated in the Venn diagram (Figure 2.1).

I
Up
GBP2
GBP6
SLFN11
IDO1
IFITM3
ACKR4
TNFSF13B
MLKL
MASTL
SP110
KIF5C
IFITM1
WARS
FOXS1
ISG20
GNGT2
SLFN12
APOL3
TMEM140
CDADC1
CD274
GHSR
HES4
CASP4
BCL2L15
DRAM1
IFI35
FAM212A
BOLA-DMB
SASS6
BPNT1
MORC3

GTF2B
STAT2
IRF8
HSH2D
OPTN
DAXX
ATXN3
GNB4
RBCK1
NMI
PLSCR2
GDAP2
MOV10
STAT1
ATAD1
LGALS3BP
AKAP7
USP25
ANXA1
SLC25A28
PARM1
NCOA7
VCPIP1
TRIM56
GRINA
SPATS2L
ATP10A
NLRC5
CNP
CBLN3
ATP8B4
MAD2L2
PSMB9
BCL2L12

BCL2L14
PSMB8
PSMF1
LEKR1
NAMPT
IRF3
TAP2
CMTR1
PAPD4
SCLY
NT5C3A
CDKN2AIP
RAB8B
ZNF607
OGFR
PSME2
ANKFY1
PXK
PSMA2
LAP3
DNAJC1
SLC25A30
SERTAD1
ERAP1
RIPK3
STK38L
TAPBP
CUL4B
NR3C1
RNF19B
AIDA
RBBP6

II
RNF31
PAPD7
SLC25A19
CCDC82
IL15RA
TRIM26
CCDC6
TRIM16
PPP2R3C
HEATR5B
IRF2
FAM111B
JADE2
DUSP11
YTHDC2
TMEM268
CHMP5
PLSCR4
CTC1
XPO1
RBMS2
NFE2L3
MAT2B
TAPBPL
PRICKLE3
NUB1
DNPEP
KIFC3
CD47
RNF139
B2M
KAT2A
AZI2
MCHR1

MITD1
TLR3
CASP8
FBXO33
RICTOR
ABHD1
RNF114
SHISA5
PLEKHA7
CDK18
PDCD4
POLH
TRIM38
C2
ARSH
XRN2
ELMO2
IRF1
RAB37
TMEM106A
TREX1
DDX19B
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Up
MX2
IFIT3
RSAD2
IFIT1
IFI44
IFIT2
ISG15
GBP4
IFI44L
SAMD9
OAS2
BST2
UBA7
USP18
ZBP1
OAS1X
MX1
GBP1
CMPK2
RTP4
RNF213
BATF2
EPSTI1
DDX58
PARP14
TNFSF10
HERC6
IFIH1
GBP5
HERC5
PLAC8
ZNFX1

EIF2AK2
SP100
IRF4
DTX3L
PML
TRIM5
IRF9
IRF7
TIFA
XAF1
PARP12
IFIT5
PARP10
PNPT1
SLC15A3
FAM3B
IFI16
SP140
TRANK1
ADAR
PLEKHA4
TRIM34
CMTR2
TDRD7
LGALS9
PARP9
IFI6
RBM43
UBE2L6
RNASEL
TRIM21
N4BP1
TAP1
TRIM25

DHX58
CASP7
IFI27

III

IV

Up

Up

ZC3HAV1

OAS1Z
LOC112441507
OAS1Y
CCDC194
SP140L
LOC107132617
CGAS
C7H19orf66
LOC112446427
TMPRSS2

V
Up
CLEC4F
CCL8
CXCL11
CXCL10
TIMD4
APOBEC3Z1
OAS1
GBP7
GVINP1
CXCL9
IFI47
MYADML
MB21D1
SECTM1
TNFSF13BL
ISG12B
LOR
CYP2J2
TCF15
KYNU
BL37
P2RY6
CLEC10A
CDHR5
RUBCN
REC8
C1ORF109
ZNF366
BL36
TLR4
EHD3
LPCAT2
AGRN

REGAKINE-1
TMEM74B
SLC2A6
BL37L
C3AR1
PTPRO
C21ORF91
PDCD1
CD53
CLEC2D
POLD3
TFEC
C19ORF66
ABCG2
STARD8
MICB
C3ORF38
HEG1
IL23A
HORMAD1
IL15
NEURL3
PTPN11
SIGLEC1
CD40
PHACTR1
ACOT9
TAL1
FRMD4B
ACSL5
TSKU
ADGRF5
DECR2
CTSS

FAM172B
C4A
IP6K1
STOML1
FAS
GSDMD
TLE4
DYSF
DYNC1H1
RAPGEF3
PARP8
SYNE2
PLPP3
LIFR
RIPK2
KYAT3
ARHGEF3
SCARF1
ZC3H12C
ZCCHC6
AIFM2
PSME1
ZNF628
TGM2
PDE5A
MTO1
MRPL32
ECM1
KIAA1033
PPFIBP1
SSAT-1
FUNDC1
PPA1
SLK

VI
TOR1AIP2
FYTTD1
IFRG15
CFLAR
PAPD5
VPS13C
JAK2
TCEAL1
USF1
MIA3
USP34
SOCS2
ABCB7
DNAJC13
GAB1
BID
MXD1
TTC9C
PHF11
UNC93B1
LDB2
PSMA8
PLA2G16
CXORF21
UNC45B
ART3
C1ORF115
NCF1
IFI27L
ALS2
MAN1C1
C2ORF68

Down

Up

KIT
CHST15
FAM101B
PECAM1
CD93
AFAP1L1
FAM124B
APLNR
SOX18
PALD1
VASH1
JAG1

CNGB1
SAA4
LYZ3
PRM1
SOX10
LOC781494
JAKMIP3
NUGGC
MUC12
LOC511617
OASL
BIRC7
LOC787234
ADGRG7
IFNL3
LOC512869
BVES
TMPRSS5
TNFSF4
SBK3
ASB5
CNDP1
FRAS1
ACVR1C
SLCO2B1
SLC22A10
OXT
ODF3L1
DPY19L2
LOC512440
ELMOD1
TRIM15
TRPC3
GPR63
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PCK1
SYT16
LOC107132327
KIF26A
ABCC11
ZC3H12D
MYAML2
LOC100141258
IL3RA
ANKRD35
LUZP2
UPB1
HS3ST1
SLC9C1
C1R
LRIT3
PLA2G7
CAPN8
LOC112445995
BREH1
SLC23A2
TAGAP
ARHGAP9
CDHR4
ABCB5
IFITM2
CLDN16
SULT6B1
TGM7
C5
MESP2
CD34
PDCD1LG2
RPE65
LOC521656

LOC512672
LOC101903126
LOC101905257
STAT4
B3GNT3
LY6L
TSPAN32
ATP8A2
CLEC2D11
GOLCA6L22
ERBB4
PSCA
C5H22orf23
THEM6
CHST4
TRIM14
LOC101905194
LOC104970178
TNFRSF9
LOC112448863
DSC1
LOC515697
LPL
LOC509972
LOC112446668
SCNN1B
GMNC
LOC616948

SLC13A5
ANKRD53
CCDC190
LOC530929
LOC101902154
CPLX1
LOC112444847
ISG12(B)
BST1
TACR1
PLA2R1
OVCH1
LOC512323
CSPG5
TAF4B
IL34
LOC782527
WDR17
SOCS1
SCN9A
ADAM19
CYP2S1
JPH2
RAB19
KRT42
MYO1A
VWA5A
FAM71A
ARID3C
IQCD
GANC
COX7A1
RIPOR3

VI Cont.
Up
MASP1
SIX1
CCDC39
SCNN1G
ZCCHC2
PMAIP1
TM6SF2
EPHX2
FBXO16
PGR
INPP5F
IQUB
NFIX
ORC5
TCTN3
EHD4
OVOL1
CATSPERE
CIITA
RAD21L1
BTC
LOC515736
GDA
DUSP15
PLIN2
ZFP36
IL22RA1
FBXO45
LOC618733
ICA1L
HSPB11
APOBEC1
DDIT3

DRAM2
FLT3LG
IL18
FAM172BP
NKX3-1
LY6E
BOLA-NC1
SFN
TMEM171
FUT10
PLA2G3
MISP
CALCOCO2
ERAP2
CCDC102A
CSDC2
ZUP1
ARL6IP1
NEB
LOC508153
CTSL
WDR86
VAMP5
SAMHD1
C16H1orf115
AP5B1
ICAM1
ICAM2
INA
CHST1
TACR3
FOXQ1
GABRP
THEM4

DENND2D
GRAMD1C
ALDH9A1
CROT
CSRNP1
TACSTD2
CLDN1
CLSTN2
FAM192A
YARS
FAM129A
AKAP6
ZNF852
LIPA
MTR
SAT1
TATDN3
BSPRY
ALPK1
NOSTRIN
XRCC5
C1H3orf38
SIDT2
CSRNP2
LENG1
TCAF2
RBMX2
MST1R
MUC1
SLC27A1
UTP23
HK2
SEMA4A
FCHSD2

LOC518495
A2ML1
TRAPPC2
LYPD6B
PRKAR1B
ZDHHC14
TICRR
TRMT13
CPOX
ITPR2
WIPF3
GIPC2
DCK
SLC6A12
ATP7A
TMEM41A
GABARAPL1
SLC25A12
CAMK2D
APOBEC3H
OSMR
LNPEP
TMEM144
FAM76A
MOCS1
UBIAD1
ACP2
AP1AR
EVA1A
C11H2orf68
PPAT
BTBD11
BOLA
HACD2

ACOX3
FBXO7
ARL6IP5
SARS
RFX5
TAF5
APRT
STXBP3
ZNF197
SERINC2
PSMB10
PRKD2
S1PR2
DDX24
GCHFR
C16H1orf112
ELF1
RRM2B
HNF4G
TWISTNB
ID4
LOC101905041
B4GALT1
EMP1
ACSS2
PCGF5
ADM2
SNX4
VPS33B
POLR2K
CGN
HKDC1
ADPGK
DNAJA1
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HFE
RNF39
DBNL
MTPAP
DNMT1
TPRKB
EIF2AK1
SPTY2D1
GALM
SLC1A5
COA7
TMEM255B
MTFP1
PRMT9
TTC4
FYB2
TSPYL1
PALM
SARNP
STARD3
DNAJC7
TXNRD1
RCBTB1
SEPT7
GYG1
TMEM230
NECTIN2
AVEN
BIRC3
MOCOS
GPHN
PLEKHO1
SCO1
APOPT1

FPGT
WDR18
F2R
TMED8
SCP2
TCOF1
MIER3
MRPL44
RNF135
DENND4C
OSBPL8
SNX6
CENPO
SEC24B
PRPSAP1
NISCH
SSBP3
ANAPC11
STRIP1
FAM110C
JDP2
PJA2
MARCKSL1
CBLL1
STAMBP
KAT5
ZNF710
HGH1
CEPT1
GTPBP2
TIPARP
CSTF1
ACADM
MTMR4

SPPL2A
PDK3
ZCCHC8
SLC35C1
NARS
KAT2B
DESI1
HAUS3
PRKAB1
FGD4
ARHGEF16
ZMYM1
CNOT9
UHRF2
DNAJC8
KCTD9
PELI1
MCL1
FAM168B
HNRNPLL
KRT7
TRIM4

Down
DESI2
MBTPS1
GNPAT
GTF2A1
ZDHHC23
PSD4
PKD1
SESN3
ENTR1
NETO2

NBEAL2
SRD5A1
VPS33A
MLEC
MEGF9
NAV2
UNC5B
TUBB3
SAMD1
BCAT1
ARVCF
PPARA
PIAS2
MTFR1
TUBA1A
PTCH1
EML1
AKAP12
LMCD1
ETV4
ALDH1A3
FITM2
SLC25A15
KLF13
SCRN1
FAM92A
GVQW3
PCDHA5
ZMYND10
HIST1H3A
MAP6

Table 3.3. The logFC of the top 20 genes up-regulated in bovine endometrial epithelial cells and
shared with explants treated with oIFNT and a d15 conceptus [143] (I and II of Figure 2.2).
The fibroblast cell logFC is listed if the gene was also up-regulated in fibroblast cells.

GenBank Acc.
Number
XM_005227105.4
XM_015473641.2
XM_002686295.6
XM_015460598.2
NM_001024557.1
XM_024993137.1
NM_001076127.2
XM_015474249.2
NM_001045941.1
NM_001075414.1
NM_174366.1
XM_003586247.5
XM_024981673.1
XM_024998051.1
XM_015471926.2
NM_001101866.2
NM_001099716.1
XM_003585891.5
NM_001206162.1
NM_178108.2

Gene
BATF2
MX2
IFI44
IFIT1
OAS2
PLAC8
KIF5C
ZBP1
RSAD2
IFIT3
ISG15
HSH2D
IFI27
ATP8B4
BST2
IDO1
FOXS1
IFI44L
IRF4
OAS1X
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Epithelial
Cell LogFC
11.88
10.26
9.95
9.65
9.51
8.96
8.66
8.47
8.46
8.15
7.94
7.86
7.85
7.52
7.25
7.18
7.17
7.09
6.97
6.78

Fibroblast
Cell LogFC
2.80
7.83
7.63
3.56
9.63
7.75
-8.06
8.35
3.36
6.90
-5.03
-6.47
--8.66
5.73
7.35

Table 3.4. Gene ontology (GO) Biological Process Direct for 223 genes up-regulated in bovine
endometrial epithelial cells treated with 100 ng of oIFNT in 3D culture (I and II of Figure
2.2).
Term

P-Value

Genes

< 0.001

RNASEL, IFITM1, IFITM3, RSAD2, OAS2, IFI35, ISG20, ISG15, XAF1,
MX1, MX2, SP100, BST2, STAT1, PSMB8, STAT2, IFIT3, IRF9, IFIT2,
IFIT1, IFI27, IRF7, IRF8, IRF1, IRF2, IRF3, IRF4, GBP2, IFI6, ADAR

< 0.001

RNASEL, IFITM1, IFITM3, PML, TLR3, RSAD2, IFI44L, OAS2, ISG20,
TRIM5, NLRC5, ISG15, MX1, MX2, DHX58, BST2, HERC5, TRIM25,
IFI16, STAT1, STAT2, IRF9, IFIT3, TRIM56, IFIT2, IFIT1, TRIM34, IFIT5,
IRF1, IRF3, SLFN11, EIF2AK2, GBP1, ADAR

Interferon-gamma-mediated
signaling pathway

< 0.001

SP100, NMI, PML, TRIM26, TRIM25, OAS2, STAT1, TRIM21, B2M, IRF9,
TRIM38, TRIM5, TRIM34, IRF7, IRF8, IRF1, IRF2, IRF3, IRF4, GBP2,
GBP1

Response to virus

< 0.001

IFIH1, BST2, IFITM1, IFITM3, RSAD2, IFI44, OAS2, ISG20, DDX58,
PSMA2, IFIT3, IFIT2, IFIT1, IRF7, EIF2AK2, MX1, MX2, DHX58, ADAR

Negative regulation of viral
genome replication

< 0.001

RNASEL, IFITM1, BST2, IFITM3, RSAD2, PARP10, IFI16, ISG20, IFIT1,
ISG15, EIF2AK2, MX1, ADAR

Negative regulation of type I
interferon production

< 0.001

DDX58, NLRC5, IFIH1, ISG15, HERC5, UBA7, UBE2L6, TRIM25, IRF3,
DHX58

Innate immune response

< 0.001

IFIH1, BST2, ANXA1, PML, HERC5, TLR3, TRIM26, TRIM25, IFI16,
TRIM21, B2M, DDX58, NLRC5, TRIM5, CASP4, IFIT5, IRF7, C2,
EIF2AK2, MX1, MX2, DHX58, ADAR, ZBP1

Protein polyubiquitination

< 0.001

DTX3L, HERC6, HERC5, RBBP6, RNF213, TRIM21, PSMB8, PSMB9,
PSMA2, PSMF1, RNF114, PSME2, RNF139, RBCK1, RNF19B, RNF31

Response to interferon-alpha

< 0.001

BST2, IFITM1, IFITM3, EIF2AK2, MX2, ADAR

Antigen processing and
presentation of endogenous
peptide antigen via MHC class
I

< 0.001

TAP2, TAP1, ERAP1, TAPBP, B2M

Response to interferon-beta

< 0.001

BST2, IFITM1, IFITM3, XAF1, STAT1

Positive regulation of I-kappa
b kinase/NF-kappa b signaling

< 0.001

TRIM5, APOL3, TRIM38, TNFSF10, BST2, CASP8, SHISA5, RBCK1,
TRIM25, IRF3, LGALS9, RNF31

< 0.001

SP100, BST2, IFITM1, NUB1, IFITM3, TRIM21

GO Biological Process Direct
Type I interferon signaling
pathway

Defense response to virus

Response to interferon-gamma
Positive regulation of
interferon-beta production

< 0.001

DDX58, IFIH1, IRF7, IRF1, TLR3, IRF3

Negative regulation of viral
release from host cell

< 0.001

TRIM5, PML, TRIM26, TRIM25, TRIM21

< 0.001
< 0.001

ISG15, HERC5, UBA7, UBE2L6
TRIM5, IFITM1, IFITM3, TRIM26, TRIM25

ISG15-protein conjugation
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Negative regulation of viral
entry into host cell
Response to type I interferon

< 0.001

TRIM56, SP100, ISG15, MX1

Apoptotic process

< 0.001

BCL2L15, BCL2L14, FAM3B, PML, NR3C1, STAT1, BCL2L12,
DAXX, PDCD4, ELMO2, TNFSF10, CASP4, CASP7, CASP8,
IRF1, IRF3, XAF1, MX1, DRAM1

Positive regulation of NFkappa b transcription factor
activity

< 0.001

TRIM5, TRIM38, RIPK3, RBCK1, TLR3, TRIM25, EIF2AK2, LGALS9,
RNF31

Positive regulation of
sequence-specific DNA
binding transcription factor
activity

< 0.001

DDX58, TRIM5, TRIM38, SP100, TRIM34, TRIM26, TRIM25, TRIM21

Positive regulation of
interferon-alpha production

< 0.001

DDX58, IFIH1, IRF7, IRF3

Positive regulation of type I
interferon production

< 0.001

IRF7, IRF1, IRF3, IFI16, DHX58, ZBP1

MDA-5 signaling pathway

< 0.001

IFIH1, IRF7, IRF3

Antigen processing and
presentation of peptide antigen
via MHC class I

< 0.001

TAP2, TAP1, ERAP1, TAPBP, B2M

Regulation of type I interferon
production

< 0.001

TRIM56, IRF7, TREX1, TRIM21

I-kappa b kinase/NF-kappa b
signaling

0.001

RIPK3, RBCK1, TIFA, TLR3, AZI2, RNF31

Proteasome-mediated
ubiquitin-dependent protein
catabolic process

0.001

PSMA2, PSMF1, TRIM38, ATXN3, PSME2, RNF139, PML, RBCK1,
PSMB8, PSMB9

Regulation of activated T cell
proliferation

0.001

CD274, RIPK3, IDO1

Cellular response to
interferon-beta

0.001

PNPT1, IRF1, TLR3, STAT1

Translesion synthesis

0.001

POLH, ISG15, UBA7, UBE2L6, TRIM25

Antigen processing and
presentation of exogenous
peptide antigen via MHC class
I, TAP-dependent

0.001

PSMA2, PSMF1, PSME2, PSMB8, PSMB9, B2M

0.001
0.001

PSMA2, PSMF1, PSME2, RIPK3, PSMB8, PSMB9
ISG15, UBA7, UBE2L6

NIK/NF-kappab signaling
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Modification-dependent
protein catabolic process
Detection of virus

0.001

DDX58, IFIH1, TLR3

Intracellular transport of viral
protein in host cell

0.001

IFIT1, TAP2, TAP1

Regulation of mRNA stability

0.001

PSMA2, PSMF1, XPO1, RNASEL, PSME2, PSMB8, PSMB9

RNA catabolic process

0.002

PNPT1, OAS2, XRN2, ISG20

Regulation of adaptive
immune response

0.002

IRF7, RIPK3, IRF1

Positive regulation of viral
entry into host cell

0.003

TRIM38, LGALS9, TRIM21

Antigen processing and
presentation of exogenous
protein antigen via MHC class
Ib, TAP-dependent

0.003

TAP2, TAP1, B2M

Tumor necrosis factormediated signaling pathway

0.003

PSMA2, PSMF1, TNFSF13B, PSME2, STAT1, PSMB8, PSMB9

Regulation of cellular amino
acid metabolic process

0.003

PSMA2, PSMF1, PSME2, PSMB8, PSMB9

Response to cytokine

0.003

IFI27, SP100, CD274, PML, STAT1

Positive regulation of extrinsic
apoptotic signaling pathway

0.004

TNFSF10, BCL2L14, PML, RBCK1

TRIF-dependent toll-like
receptor signaling pathway

0.004

IRF7, CASP8, TLR3, IRF3

Protein trimerization

0.005

TRIM5, TRIM34, TRIM21

Positive regulation of type I
interferon-mediated signaling
pathway

0.005

NLRC5, IRF7, IRF3

RNA processing

0.006

PNPT1, RBMS2, YTHDC2, DUSP11, XRN2, ADAR

Ubiquitin-dependent protein
catabolic process

0.006

PSMA2, PSMF1, ATXN3, USP18, NUB1, CUL4B, USP25, RNF213

JAK-STAT cascade

0.006

NMI, IL15RA, STAT1, STAT2

Negative regulation of innate
immune response

0.007

NMI, IFI16, DHX58

T cell receptor signaling
pathway

0.009

PSMA2, PSMF1, PSME2, RBCK1, PSMB8, PSMB9, RNF31
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Viral process

0.010

KAT2A, XPO1, SP100, MORC3, RBCK1, SP110, DAXX, GTF2B, PSMB8,
PSMB9

Regulation of innate immune
response

0.010

IRF1, ERAP1, DHX58

Negative regulation of viral
transcription

0.010

SP100, IFITM3, TRIM21

Negative regulation of
ubiquitin-protein ligase
activity involved in mitotic
cell cycle

0.010

PSMA2, PSMF1, PSME2, PSMB8, PSMB9

Immune response

0.013

GBP6, TNFSF10, TNFSF13B, IFITM3, CD274, IRF8, ACKR4, OAS2, GBP2,
IFI6, TAPBP, B2M

Positive regulation of
ubiquitin-protein ligase
activity involved in regulation
of mitotic cell cycle transition

0.013

PSMA2, PSMF1, PSME2, PSMB8, PSMB9

Histone H3 acetylation

0.015

KAT2A, JADE2, TRIM16, IRF4

Anaphase-promoting
complex-dependent catabolic
process

0.015

PSMA2, PSMF1, PSME2, PSMB8, PSMB9

Regulation of extrinsic
apoptotic signaling pathway
via death domain receptors

0.017

TNFSF10, SP100, CASP8

T cell activation

0.019

CASP8, IRF4, AZI2, HSH2D

Necroptotic process

0.019

RIPK3, TLR3, MLKL

Proteolysis involved in
cellular protein catabolic
process

0.020

PSMA2, CASP8, PSMB8, PSMB9

Defense response to protozoan

0.021

BATF2, IRF8, IRF4

Regulation of myd88dependent toll-like receptor
signaling pathway

0.024

IRF7, IRF1

Cytosol to ER transport

0.024

TAP2, TAP1

Organelle fission

0.024

MX1, MX2

Interferon-alpha production

0.024

IRF7, AZI2

0.024
0.024

DDX58, IFIH1
XRN2, ISG20

Regulation of type III
interferon production
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DNA catabolic process,
exonucleolytic
Wnt signaling pathway, planar
cell polarity pathway

0.025

PSMA2, PSMF1, PSME2, PSMB8, PSMB9

Positive regulation of NFkappa b import into nucleus

0.026

RBCK1, TLR3, LGALS9

Cellular response to
interferon-gamma

0.031

GBP6, GBP5, TLR3, LGALS9

Myeloid cell differentiation

0.033

IRF8, PML, IFI16

Protein K48-linked
deubiquitination

0.033

ATXN3, USP25, VCPIP1

Regulation of interferongamma production

0.035

ISG15, RIPK3

Cytoplasmic pattern
recognition receptor signaling
pathway in response to virus

0.035

DDX58, IFIH1

Zonula adherens maintenance

0.035

PLEKHA7, KIFC3

Interferon-beta production

0.035

TRIM56, IRF7

Response to tumor necrosis
factor

0.036

NUB1, CASP8, YTHDC2

Positive regulation of
interleukin-12 production

0.036

IRF8, TLR3, IDO1

Protein ubiquitination
involved in ubiquitindependent protein catabolic
process

0.037

HERC6, HERC5, TRIM25, CUL4B, RNF19B, RBBP6

Stimulatory C-type lectin
receptor signaling pathway

0.037

PSMA2, PSMF1, PSME2, PSMB8, PSMB9

Positive regulation of viral
genome replication

0.038

TRIM38, IFIT1, ADAR

Regulation of type I
interferon-mediated signaling
pathway

0.038

USP18, STAT1, STAT2

Inflammatory response

0.039

APOL3, NMI, CASP4, SP100, GBP5, ANXA1, TLR3, IFI16, PXK, LGALS9

0.039
0.044

CDKN2AIP, IRF7, DTX3L, IRF3, MASTL, RBBP6, CTC1
PNPT1, XRN2, ISG20

Cellular response to DNA
damage stimulus
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RNA phosphodiester bond
hydrolysis, exonucleolytic
Double-strand break repair

0.045

PARP9, DTX3L, PAPD7, MAD2L2

Defense response

0.046

TAP1, MX1, MX2, SP140

Negative regulation of
canonical Wnt signaling
pathway

0.047

PSMA2, PSMF1, PSME2, MAD2L2, PSMB8, PSMB9

Protein linear
polyubiquitination

0.047

RBCK1, RNF31

Positive regulation of
interleukin-10 secretion

0.047

CD274, LGALS9

0.047

IRF7, IRF3

Type I interferon biosynthetic
process
Regulation of tumor necrosis
factor-mediated signaling
pathway
KEGG Pathways

0.050

CASP8, RBCK1, RNF3

Influenza A

< 0.001

XPO1, IFIH1, RNASEL, PML, TLR3, RSAD2, TRIM25, OAS2, STAT1,
STAT2, DDX58, IRF9, TNFSF10, IRF7, IRF3, EIF2AK2, MX1, ADAR

Herpes simplex infection

< 0.001

RNASEL, IFIH1, SP100, PML, TLR3, OAS2, STAT1, DAXX, STAT2,
DDX58, IRF9, IFIT1, IRF7, TAP2, CASP8, TAP1, IRF3, EIF2AK2

Hepatitis C

< 0.001

DDX58, IRF9, RNASEL, IFIT1, IRF7, IRF1, TLR3, IRF3, OAS2, EIF2AK2,
STAT1, STAT2

Measles
RIG-I-like receptor signaling
pathway

< 0.001

DDX58, IRF9, IFIH1, TNFSF10, IRF7, IRF3, OAS2, EIF2AK2, MX1,
STAT1, STAT2, ADAR

< 0.001

DDX58, IFIH1, ISG15, IRF7, CASP8, TRIM25, IRF3, AZI2, DHX58

< 0.001

DDX58, IRF7, RIPK3, TREX1, IRF3, ZBP1, ADAR

Cytosolic DNA-sensing
pathway
Hepatitis B
Proteasome

0.002
0.002

DDX58, IFIH1, IRF7, CASP8, TLR3, IRF3, STAT1, STAT2
PSMA2, PSMF1, PSME2, PSMB8, PSMB9

Viral carcinogenesis
Pertussis

0.010
0.012

KAT2A, IRF9, SP100, IRF7, CASP8, IRF3, EIF2AK2, GTF2B
CASP7, IRF8, IRF1, IRF3, C2

0.012

PSME2, TAP2, TAP1, TAPBP, B2M

0.036

IRF7, CASP8, TLR3, IRF3, STAT1

Antigen processing and
presentation
Toll-like receptor
signaling pathway

81

Table 3.5. Gene ontology (GO) Biological Process Direct for (70) genes up-regulated in bovine
endometrial fibroblast cells treated with 100 ng of oIFNT in 3D culture (II and III of Figure 2.2.).

Term

P-Value

Genes

GO Biological Process Direct

Defense response to virus

< 0.001

RNASEL, ZC3HAV1, BST2, PML, HERC5, RSAD2, TRIM25,
IFI44L, OAS2, IFI16, IRF9, IFIT3, IFIT2, TRIM5, IFIT1, ISG15,
TRIM34, IFIT5, EIF2AK2, MX1, MX2, DHX58, GBP1, ADAR

Type I interferon signaling pathway

< 0.001

RNASEL, SP100, BST2, RSAD2, OAS2, IRF9, IFIT3, IFIT2,
IFIT1, IFI27, ISG15, IRF7, IRF4, XAF1, MX1, MX2, IFI6, ADAR

Response to virus

< 0.001

IFIH1, BST2, ZC3HAV1, RSAD2, IFI44, OAS2, DDX58, IFIT3,
IFIT2, IFIT1, IRF7, EIF2AK2, MX1, MX2, DHX58, ADAR

Negative regulation of viral genome
replication

< 0.001

RNASEL, IFIT1, ISG15, ZC3HAV1, BST2, RSAD2, IFI16,
PARP10, EIF2AK2, MX1, ADAR

Interferon-gamma-mediated signaling
pathway

< 0.001

IRF9, TRIM5, SP100, TRIM34, IRF7, PML, TRIM25, OAS2, IRF4,
TRIM21, GBP1

Innate immune response

< 0.001

IFIH1, BST2, ZC3HAV1, PML, HERC5, TRIM25, IFI16, TRIM21,
DDX58, TRIM5, IFIT5, IRF7, EIF2AK2, MX1, MX2, DHX58,
ADAR, ZBP1

Negative regulation of type I
interferon production

< 0.001

DDX58, IFIH1, ISG15, HERC5, UBA7, UBE2L6, TRIM25,
DHX58

ISG15-protein conjugation

< 0.001

ISG15, HERC5, UBA7, UBE2L6

Response to interferon-alpha

< 0.001

BST2, EIF2AK2, MX2, ADAR

Positive regulation of interferon-alpha
production

< 0.001

DDX58, IFIH1, ZC3HAV1, IRF7

Negative regulation of viral release
from host cell

< 0.001

TRIM5, PML, TRIM25, TRIM21

Positive regulation of type I interferon
production

< 0.001

ZC3HAV1, IRF7, IFI16, DHX58, ZBP1

Positive regulation of sequencespecific DNA binding transcription
factor activity

< 0.001

DDX58, TRIM5, SP100, TRIM34, TRIM25, TRIM21

Positive regulation of interferon-beta
production

< 0.001

DDX58, IFIH1, ZC3HAV1, IRF7

Modification-dependent protein
catabolic process

< 0.001

ISG15, UBA7, UBE2L6
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Response to type I interferon

< 0.001

SP100, ISG15, MX1

Positive regulation of I-kappa b
kinase/NF-kappa b signaling

< 0.001

TRIM5, TNFSF10, ZC3HAV1, BST2, TRIM25, LGALS9

Translesion synthesis

< 0.001

ISG15, UBA7, UBE2L6, TRIM25

Protein trimerization

< 0.001

TRIM5, TRIM34, TRIM21

Defense response

0.002

TAP1, MX1, MX2, SP140

Response to interferon-gamma

0.003

SP100, BST2, TRIM21

Protein polyubiquitination

0.004

DTX3L, HERC6, HERC5, RNF213, TRIM21

Regulation of type III interferon
production

0.007

DDX58, IFIH1

Organelle fission

0.007

MX1, MX2

Cytoplasmic pattern recognition
receptor signaling pathway in
response to virus

0.011

DDX58, IFIH1

MDA-5 signaling pathway

0.011

IFIH1, IRF7

Positive regulation of NF-kappa b
transcription factor activity

0.013

TRIM5, TRIM25, EIF2AK2, LGALS9

Response to cytokine

0.015

IFI27, SP100, PML

Peptide transport

0.018

TAP1, SLC15A3

Detection of virus
Intracellular transport of viral protein
in host cell
Positive regulation of viral entry into
host cell

0.018

DDX58, IFIH1

0.018

IFIT1, TAP1

0.025

LGALS9, TRIM21

Positive regulation of RIG-I signaling
pathway
Cellular response to interferon-alpha

0.029
0.032

ZC3HAV1, DHX58
IFIT3, IFIT2

Response to interferon-beta
Activation of innate immune response

0.032
0.036

BST2, XAF1
TRIM5, IFI16

Activation of cysteine-type
endopeptidase activity involved in
apoptotic process

0.037

IFI27, TNFSF10, PML

Negative regulation of innate immune
response

0.039

IFI16, DHX58

Positive regulation of mRNA
catabolic process

0.043

ZC3HAV1, PNPT1
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Regulation of type I interferon
production

0.046

IRF7, TRIM21

Cellular response to virus

0.046

LGALS9, ADAR

0.046

IFIT1, ZC3HAV1

Cellular response to exogenous
dsRNA
Negative regulation of viral
transcription
KEGG Pathways

0.046
Column3

Influenza A

< 0.001

Herpes simplex infection

< 0.001

Measles

< 0.001

SP100, TRIM21
Column4
IFIH1, RNASEL, PML, RSAD2, TRIM25, OAS2, IRF9, DDX58,
TNFSF10, IRF7, EIF2AK2, MX1, ADAR
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Figure 3.3. Quantitative real-time PCR analysis of MX1 gene expression in bovine endometrial
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM
± SEM. Relative expression of MX1 was greater in epithelial and fibroblast cells treated
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05).
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Figure 3.4. Quantitative real-time PCR analysis of MX2 gene expression in bovine endometrial
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM
± SEM. Relative expression of MX2 was greater in epithelial and fibroblast cells treated
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05).
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Figure 3.5. Quantitative real-time PCR analysis of OAS1 gene expression in bovine endometrial
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
only (Control; n=4) or 100 n ng/mL of oIFNT (n=3). Relative expression data are
normalized over the geometric mean of reference genes, RNF11 and SDHA. Data are
presented as LSM ± SEM. Relative expression of OAS1 was greater in epithelial and
fibroblast cells treated with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05).
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Figure 3.6. Quantitative real-time PCR analysis of LGALS3BP gene expression in bovine
endometrial (A) epithelial and (B) fibroblast cells cultured in 3D treated with either
treatment media only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression
data are normalized over the geometric mean of reference genes, RNF11 and SDHA. Data
are presented as LSM ± SEM.Relative expression of LGALS3BP was greater in epithelial
and fibroblast cells treated with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05).
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Figure 3.7. Quantitative real-time PCR analysis of LGALS9 gene expression in bovine endometrial
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM
± SEM. Relative expression of LGALS9 was greater in epithelial and fibroblast cells treated
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05).
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Figure 3.8. Quantitative real-time PCR analysis of OAS2 gene expression in bovine endometrial
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM
± SEM. Relative expression of OAS2 was greater in epithelial and fibroblast cells treated
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05).
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Figure 3.9. Quantitative real-time PCR analysis of BATF2 gene expression in bovine endometrial
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM
± SEM. Relative expression of BATF2 was greater in epithelial and fibroblast cells treated
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05).
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Figure 3.10. Quantitative real-time PCR analysis of IDO1 gene expression in bovine endometrial
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM
± SEM. Expression of IDO1 was not significantly elevated in oIFNT treated epithelial and
fibroblast cells (P > 0.05).
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Figure 3.11. Quantitative real-time PCR analysis of MAP6 gene expression in bovine endometrial
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are
normalized over the geometric mean of reference genes, RNF11 and SDHA. Data are
presented as LSM ± SEM. Expression of MAP6 decreated in oIFNT treated epithelial
cells, however, not statistically (P > 0.05). In the fibroblast cells, there was not a trend (P
> 0.05).
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Figure 3.12. Quantitative real-time PCR analysis of TNFSF13B gene expression in bovine (A)
epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media only
(Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized over
the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM ±
SEM. Relative expression of TNFSF13B was greater in epithelial and fibroblast cells treated
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05).
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Figure 3.13. Quantitative real-time PCR analysis of ZC3HAV1 gene expression in bovine
endometrial (A) epithelial and (B) fibroblast cells cultured in 3D treated with either
treatment media only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression
data are normalized over the geometric mean of reference genes, RNF11 and SDHA. Data
are presented as LSM ± SEM. The treatment of endometrial cells with oIFNT significantly
increased ZC3HAV1 expression exclusively in the fibroblast cells in comparison to the
control-treated cells. Expression of ZC3HAV1 was not different in epithelial cells (P > 0.05)
(***P < 0.001; **P < 0.01; *P < 0.05).
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Table 3.6. Quantitative real-time PCR analysis of the effect of 100 or 1000 ng of recombinant
mouse LGALS3 protein on 3D cultured epithelial and fibroblast cells. The effect of flush
fluid of a d14 pregnant ewe (FF) on epithelial and fibroblast cells gene expression was also
examined. Control cells received treatment media only. Relative expression data are
normalized over the geometric mean of reference genes, PPIA and SDHA. Data are
presented as LSM ± SEM.

Gene
RPL23A
CXCR4
DMRTA1
ISG15
LGALS3BP
LIF
PRRT3

Cell
Type

Control

FF

LGALS3
(100 ng)

LGALS3
(1000 ng)

Trt.

Contrast

Epi.
Fib.
Epi.
Fib.
Epi.
Fib.
Epi.
Fib.
Epi.
Fib.
Epi.
Fib.
Epi.
Fib.

1.44 ± 0.11
1.07 ± 0.10
5.12 ± 0.98a
0.19 ± 0.10
1.80 ± 0.38
1.78 ± 0.45
0.50 ± 5.31a
0.27 ± 7.70a
0.98 ± 0.16a
0.73 ± 0.21a
4.27 ± 0.77a
0.27 ± 0.09
0.62 ± 0.09
2.62 ± 0.83

0.93 ± 0.12
1.20 ± 0.11
9.50 ± 1.10b
0.41 ± 0.11
1.12 ± 0.42
1.38 ± 0.50
130.27 ± 5.94b
58.40 ± 8.61b
4.12 ± 0.18b
1.77 ± 0.23b
7.11 ± 0.86b
0.27 ± 0.10
0.47 ± 0.10
2.49 ± 0.93

1.04 ± 0.11
1.02 ± 0.10
4.89 ± 0.98a
0.16 ± 0.20
1.70 ± 0.38
1.28 ± 0.45
0.60 ± 5.31a
0.23 ± 7.70a
1.05 ± 0.16a
0.58 ± 0.21a
4.89 ± 0.77a
0.24 ± 0.09
0.62 ± 0.09
2.08 ± 0.83

0.99 ± 0.11
0.83 ± 0.10
4.56 ± 0.98a
0.17 ± 0.10
1.33 ± 0.38
1.41 ± 0.45
0.55 ± 5.31a
0.19 ± 7.70a
1.02 ± 0.16a
0.59 ± 0.21a
4.56 ± 0.77a
0.23 ± 0.09
0.57 ± 0.09
1.87 ± 0.83

NS
NS
< 0.05
NS
NS
NS
< 0.001
< 0.001
< 0.001
< 0.01
NS
NS
NS
NS

NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
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Figure 3.14. Model for IFNT regulation of classical and non-classical up-regulated ISGs in the
bovine endometrium during early pregnancy. The conceptus secretes IFNT which results
in the differential expression of endometrial ISGs. The genes listed were the top 10 genes
up-regulated in response to oIFNT treatment to epithelial and fibroblast cells and were
also up-regulated in endometrial explants in response a conceptus and IFNT [143].
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